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1. General Information.  
Unless otherwise stated, reactions were performed under argon using freshly purified 
solvents, which were purified using solvent purification columns purchased from 
Innovative Technology (SPS-400-6, 2005). Reactions were monitored by thin-layer 
chromatography with E. Merck silica gel 60 F254 pre-coated plates (0.25 mm). All work-up 
and purification procedures were carried out with reagent-grade solvents in air. Flash 
chromatography was performed with the indicated solvents using silica gel (particle size 
40-63 μm) purchased from Sorbent Technologies. 1H and 13C NMR spectra were recorded 
on Varian Inova-400 MHz, 500 MHz. Chemical shifts are reported relative to internal 
chloroform (CDCl3: 
1H, δ = 7.26 ppm, 13C, δ = 77.36 ppm), benzene (C6D6: 
1H, δ = 7.15 
ppm, 13C, δ = 128.62 ppm), DMSO (DMSO-d6: 
1H, δ = 2.09 ppm, 13C, δ = 20.4 ppm), 
methanol (CD3OD: 
1H, δ = 3.31 ppm, 13C, δ = 49.15 ppm) dichloromethane (CD2Cl2: 
1H, 
δ = 5.36 ppm, 13C, δ = 53.84 ppm). Coupling constants are in Hz and are reported as d 
(doublet), t (triplet), q (quartet), bs (broad singlet), and m (multiplet). Melting points were 
recorded on a Mel-Temp apparatus (Laboratory Devices). Analytical LCMS was 
performed on a Waters Acquity UPLC (Ultra Performance Liquid Chromatography 
(Waters MassLynx Version 4.1) with a Binary solvent manager, SQ mass spectrometer, 
Water 2996 PDA (PhotoDiode Array) detector, and ELSD (Evaporative Light Scattering 
Detector). An Acquity UPLC BEH C18 1.7 μm column was used for analytical UPLC-MS. 
Optical rotations were recorded on an AUTOPOL III digital polarimeter at 589 nm, and 
specific rotations are given [α]D
20 (concentration in grams/100 mL solvent). Chiral HPLC 
analysis of enantioenriched compounds was performed using a Waters 1525 Binary HPLC 
Pump with a Waters 2487 diode array detector. Preparative HPLC was performed on a 
Waters Autopurification System using a Waters SunFire™ Xbridge Prep C18 OBD™ 5µm 
19X100 mm and 19X250 mm columns. 
Materials. Chemicals were purchased from Sigma-Aldrich, Fisher or Alfa Aesar, TCI, 
Oakwood, Enamine BB, Combi-blocks, and Strem Chemicals and were used without 
further purification. 
Cells and Antibodies. MDA-MB-231 breast cancer cells were cultured in DMEM 
supplemented with 10% FBS, 2 mM L-glutamine, and 100 U/mL penicillin streptomycin, 
and grown at 37 ℃ and 5% CO2.  
RNA sequence. The bicistronic mRNA reporter was constructed by first linearizing the 
psp6(CAG)33FF/HCV/REN plasmid with BamHI.
S1 Three micrograms of the linearized 
DNA were added to an in vitro transcription reaction containing 1 mM ATP, UTP, CTP and 
m7GpppG cap analogue, 0.2 mM GTP, 0.6 U/L SP6 polymerase, and 1 U/L RNAse 
inhibitor. The in vitro transcription reaction was incubated for 3-4 hours at 37 ℃ and 
stopped by adding DNAse I to a final concentration of 0.06 U/L. The RNA was cleaned 







2. Experimental Procedures and Characterization Data 
2.1 Synthesis of Keto-Rocaglate 5a 
Synthesis of keto-rocaglate 5a was accomplished using previously reported conditions (see 
Scheme SI1).S2 
 




 To keto-rocaglate 5a (561 mg, 1.14 mmol) and a stir bar, 7 mL of a dichloromethane 
solution of triethylamine (0.5 M, 3 equiv) was added followed by 5 mL of a 
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dichloromethane solution of tosyl chloride (0.5 M, 2 equiv) at rt. The reaction was stirred 
for 2 h and was checked for completion using TLC analysis. The reaction was quenched 
with sat. aq. ammonium chloride. The crude product was obtained by extraction with ethyl 
acetate, drying through Na2SO4, filtration, and concentration. After flash chromatography 
(eluent: EA:Hex=1:3, Rf = 0.4), 627 mg (0.972 mmol) of the pure tosyl-enol rocaglate 5 
was obtained in 85% yield. A trituration (15% EA in Hex) protocol removed trace yellow 
color and provided tosyl-enol rocaglate 6a as a white powder. 1H NMR (400 MHz, CDCl3) 
δ 8.04 (d, J = 8.3 Hz, 2H), 7.38 (d, J = 8.1 Hz, 2H), 7.19 – 7.08 (m, 5H), 7.05 (d, J = 9.0 
Hz, 2H), 6.54 (d, J = 9.0 Hz, 2H), 6.13 (d, J = 1.9 Hz, 1H), 5.87 (d, J = 1.9 Hz, 1H), 4.63 
(s, 1H), 3.76 (s, 3H), 3.66 (s, 3H), 3.61 (s, 3H), 3.55 (s, 1H), 3.47 (s, 3H), 2.47 (s, 3H). 13C 
NMR (101 MHz, CDCl3) δ 163.6, 163.0, 160.9, 158.6, 157.7, 153.4, 145.2, 137.5, 134.1, 
129.5, 129.3, 129.2, 128.9, 128.0, 127.1, 126.7, 124.3, 112.0, 105.4, 99.4, 92.2, 89.7, 88.9, 





 To a solution of keto-rocaglate 5a (23.3 mg, 1.0 equiv, 0.08 M in toluene), was added 
0.12 mL of dimethylamine (5.0 equiv, 2.0 M in THF). The reaction mixture was heated to 
90 oC for 3 h prior to removal of the solvent. The obtained β-keto-rocaglamide intermediate 
was dissolved in methanol (0.1 M), and 0.1 mL NaOMe solution (2.0 equiv, 1.0 M in 
methanol) was added. The mixture was stirred for 1 h, and the methanol solvent was 
evaporated using nitrogen gas flow. To the concentrated reaction mixture, 27.2 mg of tosyl 
chloride in 0.38 mL of CH2Cl2 (3.0 equiv, 0.3 M) was added. The reaction was stirred at 
room temperature for 3 h, and the reaction was monitored by TLC analysis. The reaction 
was quenched with sat. aq. ammonium chloride. The crude product was obtained by 
extraction with ethyl acetate, drying through Na2SO4, filtration, and concentration in vacuo. 
After silica gel flash chromatography (eluent: EA:Hex=1:2, Rf = 0.3), 21.4 mg of 
compound 6z was obtained in 68% yield as a white solid. 1H NMR (400 MHz, CDCl3) δ 
7.84 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.4 Hz, 2H), 7.14 (d, J = 9.0 Hz, 2H), 7.12 – 7.07 (m, 
5H), 6.54 (d, J = 9.0 Hz, 2H), 6.10 (d, J = 1.9 Hz, 1H), 5.88 (d, J = 1.9 Hz, 1H), 4.55 (s, 
1H), 3.77 (s, 3H), 3.65 (s, 6H), 2.90 (s, 3H), 2.68 (s, 3H), 2.44 (s, 3H). 13C NMR (126 MHz, 
DMSO-d6) δ 164.2, 163.7, 161.0, 159.0, 158.0, 145.7, 145.6, 136.7, 133.6, 130.3, 129.9, 
129.5, 128.8, 128.1, 127.8, 127.5, 127.3, 112.5, 106.1, 100.9, 92.5, 89.9, 89.4, 60.8, 55.9, 
S6 
 





 The aglain Weinreb amide derivative was synthesized according to our previous 
report.S3 To 120 mg of the aglain Weinreb amide (1.0 equiv) dissolved in anhydrous 
methanol (0.03 M), 0.3 mL NaOMe solution in MeOH (1.3 equiv, 1.0 M) was added under 
a nitrogen atmosphere. The reaction mixture was heated to 60 oC for 3 h prior to the 
removal of methanol using nitrogen gas flow. The obtained crude product was dissolved in 
1 mL of CH2Cl2 which was followed by addition of 88 mg of p-TsCl (2.0 equiv) in 1 mL of 
CH2Cl2; the concentration of the reaction was 0.1 M. The reaction mixture was stirred at 
room temperature for 3 h and was monitored for completion using TLC analysis. The 
reaction was quenched with sat. aq. ammonium chloride. The crude product was obtained 
by extraction with ethyl acetate, drying through Na2SO4, filtration, and concentration. After 
a flash chromatography (eluent: EA:Hex=1:1, Rf = 0.6), 74 mg of the pure tosyl-enol RHT 
derivative 6aa was obtained in 47% yield as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 
7.95 (d, J = 7.9 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 7.15 (d, J = 9.0 Hz, 2H), 7.12 – 7.06 (m, 
5H), 6.56 (d, J = 9.0 Hz, 2H), 6.16 (s, 1H), 5.90 (s, 1H), 4.62 (s, 1H), 3.79 (s, 3H), 3.66 (s, 
3H), 3.61 (s, 3H), 3.43 (s, 3H), 3.03 (s, 3H), 2.46 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
163.9, 163.4, 160.7, 158.6, 157.7, 147.5, 145.1, 136.4, 133.5, 129.8, 129.4, 128.9, 128.7, 
127.8, 127.4, 127.1, 126.7, 112.3, 106.1, 101.2, 92.1, 88.9, 61.3, 60.0, 55.6, 55.00, 54.97, 







 Under a nitrogen atmosphere, 500 mg of tosyl-enol rocaglate 6a (1.0 equiv) was 
dissolved in 7.8 mL of THF (0.1 M) which was followed by the addition of 2.5 mL of 
DIBAL in THF (3.2 equiv, 1.0 M) at -78 oC. After stirring at -78 oC for 30 min, the reaction 
was warmed to 0 oC, stirred for an additional 4 h, and was monitored by TLC analysis. 
After completion, the reaction was quenched at -78 oC with sat. aq. ammonium chloride 
which was followed by addition of sat. aq. Rochelle salt at room temperature. The 
quenched mixture was stirred for 3 h. The crude product was obtained by extraction with 
ethyl acetate, drying through Na2SO4, filtration, and concentration in vacuo. The crude 
product was purified using flash chromatography (eluent: EA:Hex=1:1, Rf = 0.3), and 433 
mg of 6ac was obtained in 91% yield. 1H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 8.1 Hz, 
2H), 7.39 (d, J = 8.0 Hz, 2H), 7.23 – 7.07 (m, 7H), 6.55 (d, J = 9.1 Hz, 2H), 6.15 (d, J = 
2.0 Hz, 1H), 5.93 (d, J = 2.0 Hz, 1H), 4.49 (s, 1H), 4.36 (d, J = 14.1 Hz, 1H), 4.02 (d, J = 
14.0 Hz, 1H), 3.76 (s, 3H), 3.66 (s, 3H), 3.59 (s, 1H), 3.54 (s, 3H), 2.47 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ 163.2, 160.7, 158.5, 157.6, 145.5, 144.5, 136.8, 134.6, 133.1, 129.9, 
129.7, 129.1, 128.6, 128.2, 127.2, 127.2, 112.1, 106.5, 100.5, 92.1, 89.00, 88.96, 58.9, 56.9, 
55.6, 54.97, 54.96, 21.7. ESI MS m/z: 617.3, [M+H]+. 
 
(3R,3aR,8bR)-2-Formyl-8b-hydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-3-phenyl-
3a,8b-dihydro-3H-cyclopenta[b]benzofuran-1-yl 4-methylbenzenesulfonate (6y) 
 To a 50 mL round bottom flask containing 333 mg (1.0 equiv) of enol tosylate 6ac was 
added 22 mL of anhydrous CH2Cl2 (0.025 M) which was followed by 460 mg (2.0 equiv) 
of Dess-Martin periodinane (DMP). The reaction was stirred at room temperature overnight 
and was then checked for completion by TLC analysis. The crude product was obtained 
through concentration and filtration through a silica gel plug. The pure product 6y was 
obtained as pale yellow solid (327 mg) in quantitative yield. 1H NMR (400 MHz, CDCl3) 
δ 9.83 (s, 1H), 8.03 (d, J = 7.8 Hz, 2H), 7.41 (d, J = 8.0 Hz, 2H), 7.19 – 7.10 (m, 3H), 7.07 
– 7.00 (m, 4H), 6.54 (d, J = 8.3 Hz, 2H), 6.14 (d, J = 1.8 Hz, 1H), 5.95 (d, J = 1.9 Hz, 1H), 
4.60 (s, 1H), 3.77 (s, 3H), 3.66 (s, 3H), 3.62 (s, 1H), 3.59 (s, 3H), 2.48 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ 186.8, 163.8, 161.0, 158.7, 158.3, 157.8, 146.3, 136.7, 132.3, 132.1, 
129.9, 129.3, 129.2, 128.8, 128.0, 127.2, 112.1, 105.1, 100.0, 92.4, 89.7, 89.0, 56.5, 55.6, 







 To a 4 mL vial with a stir bar and 25 mg of enal tosylate 6ac (1.0 equiv) was added 
0.35 mL of THF (0.1 M) followed by 0.05 mL of a solution of MeLi (1.6 M in Et2O) at -
78 oC under nitrogen. The reaction was warmed to room temperature after addition and 
was stirred for an additional 1 h. The reaction was quenched with sat. aq. ammonium 
chloride. The crude product was obtained by extraction with ethyl acetate, drying through 
Na2SO4, filtration, and concentration. Purification of the crude product mixture using 
preparative TLC (eluent: EA:Hex = 1:1, Rf = 0.3) afforded 6.3 mg of the secondary alcohol 
6ae (25% yield). 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 8.4 
Hz, 2H), 7.29 – 7.14 (m, 5H), 7.10 (d, J = 9.1 Hz, 2H), 6.52 (d, J = 9.2 Hz, 2H), 6.12 (d, J 
= 1.9 Hz, 1H), 5.91 (d, J = 1.9 Hz, 1H), 4.81 (qd, J = 6.4, 2.9 Hz, 1H), 4.40 (s, 1H), 3.75 
(s, 3H), 3.71 (s, 1H), 3.65 (s, 3H), 3.55 (s, 3H), 2.48 (s, 3H), 2.06 (d, J = 2.6 Hz, 1H), 1.24 
(d, J = 6.7 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 163.0, 160.7, 158.5 157.5, 145.7, 144.5, 
137.9, 137.9, 133.0, 129.9, 129.7, 129.3, 128.7, 128.1, 127.3, 127.2, 112.0, 106.4, 99.7, 
92.0, 89.0, 88.8, 62.9, 58.1, 55.0, 21.8, 20.1. ESI MS m/z: 631.4, [M+H]+. 
 
(3R,3aR,8bR)-2-Acetyl-8b-hydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-3-phenyl-
3a,8b-dihydro-3H-cyclopenta[b]benzofuran-1-yl 4-methylbenzenesulfonate (6ab) 
 To an open top 4 mL vial with a stir bar and 3.3 mg of 6ae (1.0 equiv) was added 0.2 
mL of CH2Cl2 (0.025 M) which was followed by addition of 6.7 mg (3.0 equiv) of DMP. 
The reaction was stirred at room temperature overnight and was checked for completion 
by TLC analysis. The crude product was obtained by concentration followed by filtration 
through a silica gel plug. The pure product 6ab (3.2 mg) was obtained as a colorless oil in 
quantitative yield. 1H NMR (500 MHz, CDCl3) δ 8.02 (d, J = 8.3 Hz, 2H), 7.38 (d, J = 8.0 
Hz, 2H), 7.19 – 7.04 (m, 7H), 6.54 (d, J = 9.0 Hz, 2H), 6.14 (d, J = 1.9 Hz, 1H), 5.91 (d, J 
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= 1.9 Hz, 1H), 4.59 (s, 1H), 3.77 (s, 3H), 3.66 (s, 3H), 3.64 (s, 1H), 3.58 (s, 3H), 2.47 (s, 
3H), 2.20 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 195.3, 163.6, 160.9, 158.6, 157.7, 151.2, 
145.6, 137.4, 133.4, 131.7, 129.6, 129.4, 129.2, 128.9, 128.2, 127.2, 126.7, 112.1, 105.8, 
99.4, 92.3, 89.7, 89.0, 59.3, 55.6, 55.00, 54.97, 30.1, 21.8. ESI MS m/z: 629.3, [M+H]+. 
2.3 General Method for Syntheses of Amidino-Rocaglates (ADR’s): 
 
 Note: Pre-reaction azeotropic drying of amidine salts is recommended to improve the 
yield of amidino-rocaglate derivatives. However, this operation is not necessary for some 
amidine salts. 
 To an oven-dried reaction vessel with amidine or amidine salt (3.0 equiv), NaH (5.0 
equiv and 8.0 equiv, respectively), and a stir bar, anhydrous THF was added at room 
temperature under nitrogen. After stirring the mixture for 30-60 min, tosyl-enol rocaglate 
(6, 1.0 equiv) solution in THF was added at -78 oC; the overall reaction concentration is 
0.1 M in 6. The reaction mixture was stirred at -78 oC for an additional 30 min before being 
warmed to room temperature. The reaction could not be monitored by TLC analysis for 
completion, as 6 was typically consumed in 15 min at room temperature while the rate of 
generating amidino-rocaglate product was found to vary according to the specific amidine 
used in the reaction (1 h to overnight). 1H NMR of a reaction aliquot could be used to 
monitor reaction completion; an early quench of reaction may lead to production of keto-
rocaglate 5 as the major product. When slow conversion of 6 was observed, 25 mol% of 
NaHMDS (1.0 M in THF) was added at -78 oC as a catalytic proton shuttle to accelerate 
deprotonation.  
After the completion of the reaction, sat. aq. ammonium chloride was added at -78 oC 
to quench the reaction. The crude product was obtained through extraction with ethyl 
acetate, drying with Na2SO4, and concentration. Flash chromatography or preparative TLC 
was utilized to afford pure amidino-rocaglate derivatives. 
2.4 Characterization of Amidino-Rocaglates: 
Note: In acquiring 13C NMR for some amidino-rocaglates (9a, 9c, 9f, 9g, 9h, 9l, 9m, 9q, 
9w, 9ab), we found broadening of the carbon signals for C5, C8, C10, and C20 which is 
likely caused by adjacent nitrogen atoms or tautomerization of the amidine structure. Little 
improvement was achieved by changing solvent, pH, and 
concentration of NMR samples, by adjusting acquisition 
and T1 relaxation times, or employing VT NMR. As a 
representative example, the corresponding 13C signals of 9l 








1H NMR (400 MHz, CDCl3) δ 7.74 (d, J = 7.6 Hz, 2H), 7.50 
(t, J = 7.4 Hz, 1H), 7.40 (t, J = 7.6 Hz, 2H), 7.10 – 6.98 (m, 5H), 6.97 – 6.91 (m, 2H), 6.60 
(d, J = 8.5 Hz, 2H), 6.35 (d, J = 1.9 Hz, 1H), 6.11 (d, J = 1.9 Hz, 1H), 5.26 (s, 1H), 4.59 (s, 
1H), 4.30 (d, J = 14.5 Hz, 1H), 3.98 (d, J = 14.7 Hz, 1H), 3.85 (s, 3H), 3.76 (s, 3H), 3.73 
(s, 3H), 3.68 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 169.8, 164.3, 162.0, 160.2, 158.6, 
157.0, 136.2, 131.7, 128.6, 128.0, 127.9, 127.79, 127.77, 126.6, 112.8, 106.7, 103.8, 102.5, 
92.9, 89.7, 84.5, 58.1, 55.80, 55.77, 55.2, 55.1, 52.4. Eluent: 10% acetone in CH2Cl2 (Rf = 






1H NMR (500 MHz, CDCl3) δ 7.07 – 7.00 (m, 3H), 6.98 (d, 
J = 9.0 Hz, 2H), 6.95 – 6.90 (m, 2H), 6.65 (d, J = 9.2 Hz, 2H), 6.31 (d, J = 2.0 Hz, 1H), 
6.11 (d, J = 2.0 Hz, 1H), 4.36 (s, 1H), 4.21 (d, J = 14.4 Hz, 1H), 3.88 (d, J = 14.4 Hz, 1H), 
3.83 (s, 3H), 3.79 (s, 3H), 3.73 (s, 3H), 3.70 (s, 3H), 1.99 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 169.9, 164.0, 161.9, 160.0, 158.5, 156.9, 136.3, 128.1, 127.84, 127.75, 127.6, 
126.6, 112.8, 106.6, 104.3, 102.3, 92.8, 89.6, 84.7, 58.0, 55.8, 55.7, 55.1, 54.7, 52.3, 15.5. 






1H NMR (400 MHz, CDCl3) δ 7.07 – 7.01 (m, 3H), 6.98 (d, 
J = 9.0 Hz, 2H), 6.96 – 6.91 (m, 2H), 6.63 (d, J = 9.1 Hz, 2H), 6.31 (d, J = 2.0 Hz, 1H), 
6.11 (d, J = 2.0 Hz, 1H), 4.70 (s, 1H), 4.32 (s, 1H), 4.23 (d, J = 14.4 Hz, 1H), 3.89 (d, J = 
14.5 Hz, 1H), 3.84 (s, 3H), 3.78 (s, 3H), 3.73 (s, 3H), 3.70 (s, 3H), 2.37 (dt, J = 15.2, 8.0 
Hz, 1H), 2.21 (ddd, J = 14.6, 8.7, 6.2 Hz, 1H), 1.71 – 1.46 (m, 2H), 0.96 (t, J = 7.3 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ 170.0, 165.4, 164.0, 160.0, 158.5, 156.9, 136.4, 128.1, 
127.9, 127.8, 126.5, 112.7, 106.8, 104.5, 102.2, 92.8, 89.6, 84.2, 58.2, 55.8, 55.5, 55.1, 








1H NMR (500 MHz, CDCl3) δ 7.08 – 7.00 (m, 3H), 6.98 (d, 
J = 9.1 Hz, 2H), 6.96 – 6.92 (m, 2H), 6.63 (d, J = 9.1 Hz, 
2H), 6.31 (d, J = 1.9 Hz, 1H), 6.11 (d, J = 2.0 Hz, 1H), 4.29 (s, 1H), 4.23 (d, J = 14.4 Hz, 
1H), 3.88 (d, J = 14.4 Hz, 1H), 3.83 (s, 3H), 3.78 (s, 3H), 3.73 (s, 3H), 3.70 (s, 3H), 2.43 – 
2.32 (m, 1H), 2.28 – 2.17 (m, 1H), 1.65 – 1.42 (m, 3H), 1.40 – 1.30 (m, 3H), 0.88 (t, J = 
7.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 170.0, 165.6, 164.0, 160.0, 158.5, 156.9, 136.4, 
128.1, 127.9, 127.76, 127.75, 126.5, 107.0, 104.4, 102.2, 92.8, 89.6, 58.2, 55.8, 55.5, 55.1, 







1H NMR (500 MHz, CDCl3) δ 7.26 – 7.15 (m, 5H), 7.08 – 
6.99 (m, 3H), 6.97 – 6.88 (m, 4H), 6.58 (d, J = 8.8 Hz, 2H), 
6.27 (s, 1H), 6.05 (s, 1H), 4.55 (s, 1H), 4.30 (s, 1H), 4.22 (d, J = 14.4 Hz, 1H), 3.94 – 3.86 
(m, 2H), 3.81 (s, 3H), 3.76 (s, 3H), 3.71 (s, 3H), 3.69 (s, 3H), 3.52 (d, J = 14.3 Hz, 2H). 
13C NMR (126 MHz, CDCl3) δ 169.9, 164.0, 163.9, 160.0, 158.5, 156.8, 136.3, 134.8, 
129.1, 128.7, 128.0, 127.9, 127.8, 127.6, 127.2, 126.6, 112.7, 107.2, 104.1, 102.2, 92.7, 
89.5, 84.3, 58.0, 55.8, 55.4, 55.1, 54.9, 52.4, 36.5. Eluent: 1% MeOH in CH2Cl2 (Rf = 0.3). 






1H NMR (500 MHz, CDCl3) δ 7.09 – 7.01 (m, 3H), 7.00 – 
6.95 (m, 4H), 6.62 (d, J = 8.6 Hz, 2H), 6.31 (d, J = 2.0 Hz, 
1H), 6.11 (d, J = 2.0 Hz, 1H), 4.70 (s, 1H), 4.27 (d, J = 14.5 Hz, 1H), 4.21 (s, 1H), 3.86 (d, 
J = 14.5 Hz, 1H), 3.83 (s, 3H), 3.77 (s, 3H), 3.71 (s, 3H), 3.69 (s, 3H), 1.18 (s, 9H). 13C 
NMR (126 MHz, CDCl3) δ 172.0, 170.0, 164.0, 160.0, 158.5, 157.0, 136.5, 128.2, 127.93, 
127.86, 127.7, 126.5, 112.6, 107.3, 104.5, 102.1, 92.8, 89.6, 84.3, 58.4, 55.8, 55.5, 55.4, 







1H NMR (500 MHz, CDCl3) δ 7.08 – 7.00 (m, 3H), 7.00 – 
6.93 (m, 4H), 6.62 (d, J = 9.1 Hz, 2H), 6.31 (d, J = 1.9 Hz, 
1H), 6.11 (d, J = 1.9 Hz, 1H), 4.25 (d, J = 14.4 Hz, 1H), 3.90 
(d, J = 14.5 Hz, 1H), 3.83 (s, 3H), 3.77 (s, 3H), 3.73 (s, 3H), 
3.69 (s, 3H), 2.76 (dt, J = 13.8, 6.2 Hz, 1H), 1.17 (d, J = 7.0 Hz, 3H), 1.07 (d, J = 7.0 Hz, 
3H). 13C NMR (126 MHz, CDCl3) δ 169.9, 164.0, 160.0, 158.5, 157.0, 136.4, 128.1, 127.88, 
127.85, 127.75, 126.5, 112.7, 106.1, 104.4, 102.1, 92.8, 89.6, 84.3, 58.2, 55.8, 55.5, 55.2, 







1H NMR (500 MHz, CDCl3) δ 7.07 – 7.00 (m, 3H), 6.97 (d, 
J = 9.0 Hz, 2H), 6.95 – 6.91 (m, 2H), 6.62 (d, J = 9.1 Hz, 2H), 6.30 (d, J = 2.0 Hz, 1H), 
6.10 (d, J = 1.9 Hz, 1H), 4.75 (s, 1H), 4.27 (s, 1H), 4.23 (d, J = 14.4 Hz, 1H), 3.88 (d, J = 
14.4 Hz, 1H), 3.83 (s, 3H), 3.77 (s, 3H), 3.72 (s, 3H), 3.70 (s, 3H), 2.51 (s, 1H), 1.91 (d, J 
= 8.3 Hz, 1H), 1.86 (d, J = 12.7 Hz, 1H), 1.80 – 1.69 (m, 2H), 1.66 (d, J = 12.9 Hz, 1H), 
1.36 – 1.21 (m, 3H), 1.20 – 1.03 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 169.9, 169.3, 
164.0, 160.0, 158.5, 157.0, 136.4, 128.1, 127.9, 127.8, 127.7, 126.5, 112.6, 106.4, 104.4, 
102.0, 92.8, 89.6, 84.3, 58.1, 55.8, 55.5, 55.2, 55.1, 52.3, 39.2, 30.5, 30.1, 25.8, 25.6. Eluent: 






9i was found as a pair of amidine tautomers; NMR signals 
for the major tautomer are provided. 1H NMR (400 MHz, CDCl3) δ 7.06 (d, J = 6.0 Hz, 
3H), 6.97 (t, J = 8.3 Hz, 4H), 6.69 – 6.64 (m, 2H), 6.33 (d, J = 1.8 Hz, 1H), 6.13 (d, J = 2.1 
Hz, 1H), 5.16 (s, 1H), 4.48 (s, 1H), 4.27 (d, J = 14.5 Hz, 1H), 3.92 (d, J = 14.5 Hz, 1H), 
3.85 (s, 3H), 3.81 (s, 3H), 3.75 (s, 3H), 3.70 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 169.3, 
164.7, 160.2, 158.8, 157.0, 152.6 (q, J = 38.4 Hz), 135.6, 127.9, 127.8, 127.4, 127.3, 126.8, 
117.2 (d, J = 275.6 Hz), 113.1, 106.9, 102.5, 98.1, 93.0, 89.7, 84.7, 58.9, 57.8, 55.8, 55.1, 
54.9, 52.5. 19F NMR (376 MHz, CDCl3) δ -70.2. Eluent: 1% MeOH in CH2Cl2 (Rf = 0.6). 








1H NMR (400 MHz, CDCl3) δ 8.16 (s, 2H), 7.10 – 7.04 (m, 
3H), 6.97 – 6.87 (m, 4H), 6.65 (d, J = 8.7 Hz, 2H), 6.31 (d, J = 1.8 Hz, 1H), 6.14 (d, J = 
1.9 Hz, 1H), 4.96 (s, 1H), 4.18 (d, J = 14.5 Hz, 1H), 3.98 (d, J = 14.5 Hz, 1H), 3.84 (s, 3H), 
3.81 (s, 3H), 3.67 (s, 3H), 3.65 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 168.2, 165.1, 160.4, 
159.0, 156.9, 156.3, 135.0, 127.9, 127.7, 127.5, 127.0, 126.1, 113.6, 101.6, 100.8, 95.9, 
93.6, 90.1, 84.4, 57.4, 56.4, 55.9, 55.2, 54.8, 52.4. Eluent: 6% MeOH in CH2Cl2 (Rf = 0.1). 






1H NMR (400 MHz, CDCl3) δ 7.14 – 7.01 (m, 3H), 7.01 – 
6.92 (m, 4H), 6.63 (d, J = 8.7 Hz, 2H), 6.33 (d, J = 2.0 Hz, 
1H), 6.12 (d, J = 2.0 Hz, 1H), 5.33 (s, 1H), 4.34 (s, 1H), 4.24 (d, J = 14.4 Hz, 1H),  4.21 
(q, J = 14.7 Hz, 1H), 3.90 (d, J = 14.4 Hz, 1H), 3.84 (s, 3H), 3.78 (s, 3H), 3.74 (s, 3H), 3.69 
(s, 3H), 3.26 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 169.8, 164.1, 163.0, 160.1, 158.6, 
156.9, 136.3, 128.0, 127.9, 127.8, 127.7, 126.6, 112.8, 107.3, 104.0, 102.4, 92.9, 89.7, 83.5, 
68.3, 59.0, 58.1, 55.8, 55.6, 55.1, 54.7, 52.3. ESI Eluent: 3% MeOH in CH2Cl2 (Rf = 0.3). 






1H NMR (500 MHz, CDCl3) δ 7.08 – 7.01 (m, 3H), 6.99 – 
6.92 (m, 4H), 6.64 (d, J = 9.1 Hz, 2H), 6.32 (d, J = 2.0 Hz, 
1H), 6.12 (d, J = 1.9 Hz, 1H), 5.21 (s, 1H), 4.39 (s, 1H), 4.29 (d, J = 12.8 Hz, 1H), 4.24 (d, 
J = 14.4 Hz, 1H), 4.17 (d, J = 13.1 Hz, 1H), 3.90 (d, J = 14.4 Hz, 1H), 3.84 (s, 3H), 3.80 
(s, 3H), 3.74 (s, 3H), 3.70 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 169.6, 164.3, 160.3, 
160.1, 158.6, 156.9, 136.0, 127.82, 127.80, 127.7, 127.6, 126.7, 112.9, 107.1, 103.7, 102.3, 
92.9, 89.7, 84.6, 57.9, 55.8, 55.7, 55.1, 54.9, 52.4, 38.4. Eluent: 3% MeOH in CH2Cl2 (Rf 







1H NMR (500 MHz, CDCl3) δ 7.07 – 7.00 (m, 3H), 7.00 – 
6.91 (m, 4H), 6.62 (d, J = 9.2 Hz, 2H), 6.31 (d, J = 2.0 Hz, 
1H), 6.11 (d, J = 2.0 Hz, 1H), 4.73 (s, 1H), 4.29 (s, 1H), 4.24 
(d, J = 14.4 Hz, 1H), 3.87 (d, J = 14.4 Hz, 1H), 3.83 (s, 3H), 
3.78 (s, 3H), 3.72 (s, 3H), 3.69 (s, 3H), 3.22 (p, J = 8.6 Hz, 1H), 2.26 – 2.13 (m, 3H), 2.12 
– 1.91 (m, 2H), 1.85 – 1.74 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 170.0, 167.7, 164.0, 
160.0, 158.5, 157.0, 136.4, 128.1, 127.9, 127.8, 127.7, 126.5, 112.7, 107.0, 104.5, 102.2, 
92.8, 89.6, 84.0, 58.2, 55.8, 55.6, 55.09, 55.06, 52.3, 34.2, 26.1, 25.8, 18.7. Eluent: 1% 






1H NMR (400 MHz, CDCl3) δ 7.10 – 7.00 (m, 3H), 7.00 – 
6.89 (m, 4H), 6.65 (d, J = 8.5 Hz, 2H), 6.30 (d, J = 2.0 Hz, 1H), 6.11 (d, J = 2.0 Hz, 1H), 
4.21 (d, J = 14.4 Hz, 1H), 3.86 (d, J = 14.4 Hz, 1H), 3.83 (s, 3H), 3.80 (s, 3H), 3.72 (s, 3H), 
3.71 (s, 3H), 1.65 (bs, 1H), 0.97 – 0.81 (m, 3H), 0.70 (bs, 1H). 13C NMR (126 MHz, CDCl3) 
δ 170.0, 166.7, 164.0, 160.0, 158.5, 156.9, 136.4, 128.1, 127.9, 127.8, 127.7, 126.5, 112.7, 
106.6, 104.6, 102.1, 92.8, 89.6, 84.0, 58.2, 55.8, 55.7, 55.1, 55.0, 52.3, 9.9, 7.5, 6.5. Eluent: 




After purification, we found 
adducts 9o and 9o’ to be 
inseparable regioisomers. 
Their ratio was determined by 
1H NMR analysis (9o:9o’ = 
8:1). Some carbon signals for 
9o were determined from 2D 
NMR experiments. 1H NMR 
(400 MHz, CDCl3) δ 7.09 – 6.99 (m, 5H), 6.99 – 6.92 (m, 2H), 6.62 (d, J = 8.7 Hz, 2H), 
6.34 (d, J = 1.9 Hz, 1H), 6.11 (d, J = 1.9 Hz, 1H), 4.24 (d, J = 14.5 Hz, 1H), 3.99 (d, J = 
14.5 Hz, 1H), 3.85 (s, 3H), 3.78 (s, 3H), 3.75 (s, 3H), 3.70 (s, 3H), 2.63 – 2.39 (m, 3H), 
2.07 – 1.97 (m, 2H), 1.93 – 1.80 (m, 1H). 13C NMR (101 MHz, CDCl3) δ 171.5, 169.9, 
164.2, 160.4, 158.5, 157.1, 136.3, 128.5, 127.9, 127.8, 127.2, 126.6, 112.7, 102.6, 100.90, 
92.3, 89.7, 86.4 58.4, 55.8, 55.69, 55.65, 55.0, 52.3, 42.0, 24.1, 23.9. Eluent: 5% MeOH in 










carboxylate (9p)  
After purification, we found that 9p and 9p’ are inseparable regioisomers. Their ratio was 
determined by 1H NMR analysis (9p:9p’ = 3:1). Some carbon signals for 9p and 9p’ were 
determined with the assistance from 2D NMR experiments. 1H NMR (500 MHz, CDCl3) δ 
7.09 – 6.97 (m, 5H), 6.91 – 6.88 (m, 2H), 6.64 (d, J = 8.6 Hz, 2H), 6.34 (d, J = 1.9 Hz, 1H), 
6.12 (d, J = 1.9 Hz, 1H), 4.17 (d, J = 14.4 Hz, 1H), 3.87 (d, J = 14.4 Hz, 1H), 3.85 (s, 3H), 
3.79 (s, 3H), 3.72 (s, 3H), 3.71 (s, 3H), 2.70 (dt, J = 17.4, 4.7 Hz, 1H), 2.49 (ddd, J = 16.9, 
10.2, 5.6 Hz, 1H), 2.26 (td, J = 10.4, 9.9, 4.7 Hz, 1H), 1.96 (dt, J = 10.6, 4.8 Hz, 1H), 1.67 
– 1.60 (m, 1H), 1.51 – 1.37 (m, 2H), 1.16 – 1.05 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 
170.0, 164.1, 162.4, 160.4, 158.6, 157.1, 136.3, 128.1, 127.9, 127.7, 127.3, 126.5, 112.6, 
104.5, 101.7, 101.4, 92.4, 89.8, 87.5, 58.3, 55.7, 55.6, 55.2, 55.1, 52.2, 41.9, 26.3, 22.7, 





1H NMR (500 MHz, CDCl3) δ 7.09 – 6.97 (m, 5H), 6.92 (d, J = 8.9 Hz, 2H), 6.60 (d, J = 
9.0 Hz, 2H), 6.34 (d, J = 1.9 Hz, 1H), 6.10 (d, J = 1.9 Hz, 1H), 4.38 (d, J = 14.1 Hz, 1H), 
3.86 (d, J = 14.1 Hz, 1H), 3.82 (s, 3H), 3.79 (s, 3H), 3.76 (t, J = 5.6 Hz, 1H), 3.68 (s, 3H), 
3.66 (s, 3H), 3.50 (ddd, J = 11.9, 9.1, 4.9 Hz, 1H), 2.41 (d, J = 16.7 Hz, 1H), 2.05 (ddd, J 
= 16.2, 9.5, 5.3 Hz, 1H), 2.01 – 1.86 (m, 2H), 1.79 (t, J = 10.2 Hz, 1H), 1.66 (s, 1H). 13C 
NMR (126 MHz, CDCl3) δ 169.9, 163.4, 160.1, 158.9, 158.2, 156.7, 136.6, 128.4, 127.9, 
127.8, 127.7, 126.5, 112.4, 107.4, 103.2, 99.4, 93.2, 90.2, 57.6, 56.1, 55.7, 55.0, 54.5, 52.1, 






1H NMR (500 MHz, CDCl3) δ 7.68 (d, J = 8.8 Hz, 2H), 
7.08 – 7.02 (m, 3H), 7.00 (d, J = 8.8 Hz, 2H), 6.96 – 
S16 
 
6.87 (m, 4H), 6.58 (d, J = 9.1 Hz, 2H), 6.34 (d, J = 2.0 Hz, 1H), 6.10 (d, J = 2.0 Hz, 1H), 
4.28 (d, J = 14.4 Hz, 1H), 3.95 (d, J = 14.4 Hz, 1H), 3.84 (s, 3H), 3.83 (s, 3H), 3.74 (s, 3H), 
3.72 (s, 3H), 3.67 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 169.9, 164., 162.3, 161.7, 160.1, 
158.5, 156.9, 136.3, 129.5, 128.1, 127.9, 127.8, 127.7, 126.6, 121.7, 113.9, 112.7, 107.2, 
104.3, 102.4, 92.8, 89.7, 84.5, 58.2, 55.79, 55.75, 55.4, 55.2, 55.1, 52.4. Eluent: 10% 






1H NMR (500 MHz, CDCl3) δ 7.84 (d, J = 8.1 Hz, 2H), 
7.67 (d, J = 8.1 Hz, 2H), 7.10 – 7.03 (m, 3H), 7.00 (d, J 
= 8.5 Hz, 2H), 6.97 – 6.93 (m, 2H), 6.60 (d, J = 9.1 Hz, 2H), 6.35 (d, J = 1.9 Hz, 1H), 6.12 
(d, J = 2.0 Hz, 1H), 5.12 (s, 1H), 4.56 (s, 1H), 4.30 (d, J = 14.4 Hz, 1H), 3.97 (d, J = 14.5, 
1.4 Hz, 1H), 3.85 (s, 3H), 3.76 (s, 3H), 3.73 (s, 3H), 3.68 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 169.8, 164.3, 160.6, 160.2, 158.6, 156.9, 136.1, 133.2 (q, J = 32.9 Hz), 133.0, 
128.2, 128.0, 127.9, 127.8, 127.7, 126.7, 125.6 (q, J = 3.4 Hz), 123.7 (q, J = 272.5 Hz) 
112.8, 107.3, 103.8, 102.6, 92.9, 89.7, 84.5, 58.1, 55.8, 55.8, 55.10, 55.05, 52.5. 19F NMR 







1H NMR (500 MHz, CDCl3) δ 7.59 (d, J = 8.6 Hz, 2H), 
7.53 (d, J = 8.6 Hz, 2H), 7.08 – 7.02 (m, 3H), 6.98 (d, J 
= 8.5 Hz, 2H), 6.95 – 6.90 (m, 2H), 6.59 (d, J = 9.0 Hz, 2H), 6.34 (d, J = 1.9 Hz, 1H), 6.10 
(d, J = 2.0 Hz, 1H), 5.07 (s, 1H), 4.53 (d, J = 1.4 Hz, 1H), 4.28 (d, J = 14.4 Hz, 1H), 3.95 
(dd, J = 14.4, 1.4 Hz, 1H), 3.84 (s, 3H), 3.75 (s, 3H), 3.72 (s, 3H), 3.67 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 169.8, 164.2, 161.1, 160.2, 158.6, 156.9, 136.2, 131.9, 129.3, 128.5, 
128.0, 127.9, 127.8, 127.7, 126.6, 126.1, 112.8, 107.4, 103.9, 102.5, 92.8, 89.7, 84.4, 58.0, 










1H NMR (500 MHz, CDCl3) δ 7.65 (d, J = 8.9 Hz, 2H), 
7.07 – 7.01 (m, 3H), 7.00 (d, J = 8.9 Hz, 2H), 6.93 – 6.88 (m, 2H), 6.65 (d, J = 9.0 Hz, 2H), 
6.58 (d, J = 9.1 Hz, 2H), 6.33 (d, J = 2.0 Hz, 1H), 6.09 (d, J = 2.0 Hz, 1H), 4.65 (s, 1H), 
4.27 (d, J = 14.4 Hz, 1H), 3.96 (d, J = 14.4 Hz, 1H), 3.83 (s, 3H), 3.74 (s, 3H), 3.71 (s, 3H), 
3.66 (s, 3H), 3.01 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 170.0, 164.0, 161.9, 160.1, 158.4, 
157.0, 152.6, 136.4, 129.4, 128.1, 127.92, 127.86, 127.7, 126.5, 115.5, 112.7, 111.2, 104.6, 
102.2, 92.8, 89.6, 58.2, 55.78, 55.75, 55.3, 55.1, 52.3, 40.1. Eluent: 1% MeOH in CH2Cl2 






1H NMR (500 MHz, CDCl3) δ 8.21 (s, 1H), 7.09 – 7.01 (m, 
3H), 6.97 (d, J = 8.8 Hz, 2H), 6.92 – 6.88 (m, 2H), 6.55 (d, 
J = 8.5 Hz, 2H), 6.33 (d, J = 2.0 Hz, 1H), 6.10 (d, J = 2.0 Hz, 1H), 6.00 (s, 1H), 4.58 (s, 
1H), 4.25 (d, J = 14.4 Hz, 1H), 3.94 (d, J = 14.4 Hz, 1H), 3.83 (s, 3H), 3.73 (s, 6H), 3.65 
(s, 3H), 2.61 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 169.9, 166.0, 164.0, 160.0, 158.4, 
157.0, 156.5, 144.7, 136.3, 127.9, 127.7, 126.6, 122.7, 112.8, 107.7, 104.3, 102.1, 92.9, 
89.6, 83.8, 58.3, 55.8, 55.7, 55.0, 52.3, 19.1. Eluent: 2% MeOH in CH2Cl2 (Rf = 0.4). ESI 






1H NMR (400 MHz, CDCl3) δ 8.79 (s, 1H), 8.68 (d, J = 4.8 
Hz, 1H), 8.13 (d, J = 7.9 Hz, 1H), 7.36 (dd, J = 7.9, 5.0 Hz, 
1H), 7.11 – 7.01 (m, 3H), 7.01 – 6.90 (m, 4H), 6.59 (d, J = 8.5 Hz, 2H), 6.35 (d, J = 1.9 
Hz, 1H), 6.11 (d, J = 1.9 Hz, 1H), 5.24 (s, 1H), 4.58 (s, 1H), 4.30 (d, J = 14.4 Hz, 1H), 3.97 
(d, J = 14.5 Hz, 1H), 3.84 (s, 3H), 3.76 (s, 3H), 3.74 (s, 3H), 3.67 (s, 3H). 13C NMR (126 
MHz, CDCl3) δ 169.8, 164.3, 160.2, 159.7, 158.6, 156.9, 152.3, 148.5, 136.1, 135.6, 127.94, 
127.85, 127.81, 127.6, 126.7, 125.8, 123.5, 112.9, 107.2, 103.7, 102.7, 92.9, 89.7, 84.5, 









1H NMR (400 MHz, CDCl3) δ 7.09 – 7.01 (m, 5H), 6.99 – 
6.95 (m, 2H), 6.67 (d, J = 9.1 Hz, 2H), 6.31 (d, J = 2.0 Hz, 
1H), 6.11 (d, J = 2.0 Hz, 1H), 4.27 (d, J = 14.4 Hz, 1H), 4.00 (d, J = 14.3 Hz, 1H), 3.83 (s, 
3H), 3.81 (s, 3H), 3.70 (s, 3H), 3.66 (s, 3H), 3.66 – 3.53 (m, 2H), 3.46 – 3.37 (m, 2H), 3.32 
– 3.22 (m, 2H). 13C NMR (101 MHz, CDCl3) δ 169.8, 164.3, 160.2, 158.7, 157.9, 157.2, 
136.2, 128.5, 127.9, 127.8, 127.7, 126.6, 125.90 112.9, 105.9, 103.8, 101.6, 93.1, 89.7, 
84.9, 66.2, 58.4, 55.8, 55.8, 55.1, 54.9, 52.3, 46.3. Eluent: 2% MeOH in CH2Cl2 (Rf = 0.1). 







1H NMR (400 MHz, CDCl3) δ 7.12 – 7.00 (m, 3H), 7.00 
– 6.91 (m, 4H), 6.63 (d, J = 8.5 Hz, 2H), 6.31 (d, J = 2.0 Hz, 1H), 6.10 (d, J = 1.9 Hz, 1H), 
4.74 (s, 1H), 4.24 (d, J = 14.4 Hz, 1H), 4.17 (s, 1H), 4.14 – 4.01 (m, 2H), 3.87 (d, J = 14.6 
Hz, 1H), 3.83 (s, 3H), 3.77 (s, 3H), 3.73 (s, 3H), 3.70 (s, 3H), 2.79 – 2.54 (m, 3H), 1.80 
(dd, J = 33.9, 13.2 Hz, 2H), 1.58 – 1.28 (m, 2H), 1.40 (s, 9H). 13C NMR (101 MHz, CDCl3) 
δ 169.8, 167.5, 164.1, 160.0, 158.6, 156.9, 154.4, 136.3, 128.1, 127.82, 127.80, 127.75, 
126.6, 112.7, 106.8, 104.1, 102.1, 92.8, 89.6, 84.1, 79.6, 58.1, 55.8, 55.5, 55.1, 52.4, 43.5, 





Using tosyl-enol rocaglaldehyde substrate 6y, we found that 
1H-imidazole enal 9y was formed through dehydration. The 
structure of 9y was confirmed using 2D NMR experiments. 
1H NMR (400 MHz, CDCl3) δ 10.00 (s, 1H), 7.08 – 6.91 (m, 5H), 6.82 – 6.72 (m, 2H), 
6.59 (d, J = 8.5 Hz, 2H), 6.32 (d, J = 1.9 Hz, 1H), 6.14 (s, 1H), 5.66 (s, 1H), 4.79 (s, 1H), 
3.86 (s, 3H), 3.79 (s, 3H), 3.69 (s, 3H), 2.33 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 184.4, 
180.7, 176.0, 164.2, 160.3, 158.9, 157.9, 136.5, 129.2, 127.1, 126.7, 126.6, 126.4, 118.0, 
112.7, 108.0, 102.7, 93.2, 89.1, 85.3, 65.4, 55.8, 55.7, 55.1, 16.8. Eluent: 1% MeOH in 







1H NMR (500 MHz, CDCl3) δ 7.08 – 6.97 (m, 5H), 6.97 – 
6.94 (m, 2H), 6.68 (d, J = 9.2 Hz, 1H), 6.31 (d, J = 2.0 Hz, 
1H), 6.08 (d, J = 2.0 Hz, 1H), 4.60 (s, 1H), 4.56 (d, J = 13.6 
Hz, 1H), 4.04 (d, J = 13.6 Hz, 1H), 3.83 (s, 3H), 3.76 (s, 3H), 3.71 (s, 3H), 3.54 (s, 3H), 
2.95 (s, 3H), 1.90 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 168.5, 163.9, 161.3, 160.2, 158.4, 
157.1, 137.3, 128.8, 127.8, 127.7, 127.5, 126.2, 112.9, 107.0, 104.0, 102.6, 92.8, 89.6, 84.9, 
55.8, 55.61, 55.58, 55.4, 55.1, 37.8, 36.0, 15.4. Eluent: 5% MeOH in CH2Cl2 (Rf = 0.3). 





1H NMR (400 MHz, CDCl3) δ 7.14 – 6.95 (m, 7H), 6.66 (d, 
J = 9.0 Hz, 2H), 6.31 (d, J = 1.9 Hz, 1H), 6.08 (d, J = 2.0 
Hz, 1H), 4.86 (s, 1H), 4.47 (d, J = 14.1 Hz, 1H), 4.26 (d, J 
= 14.3 Hz, 1H), 4.02 (s, 3H), 3.83 (s, 3H), 3.76 (s, 3H), 3.70 (s, 3H), 3.18 (s, 3H), 1.88 (s, 
3H). 13C NMR (101 MHz, CDCl3) δ 170.6, 163.8, 160.5, 160.1, 158.3, 157.2, 136.9, 128.8, 
127.9, 127.7, 127.6, 126.3, 112.8, 104.7, 102.4, 92.9, 89.6, 62.0, 55.7, 55.1, 55.0, 54.4, 





1H NMR (400 MHz, CDCl3) δ 7.10 – 6.96 (m, 5H), 6.94 – 
6.87 (m, 2H), 6.67 (d, J = 8.6 Hz, 2H), 6.31 (d, J = 1.8 Hz, 
1H), 6.11 (d, J = 1.9 Hz, 1H), 4.22 (d, J = 13.9 Hz, 1H), 3.94 
(d, J = 14.0 Hz, 1H), 3.84 (s, 3H), 3.80 (s, 3H), 3.71 (s, 3H), 2.44 (s, 3H), 1.99 (s, 3H). 13C 
NMR (101 MHz, CDCl3) δ 203.8, 164.0, 161.7, 160.1, 158.5, 156.9, 136.8, 128.4, 127.9, 
127.7, 127.5, 126.4, 112.8, 107.3, 104.1, 102.6, 92.8, 89.6, 84.9, 64.8, 55.8, 55.7, 55.1, 





When tosyl-enol rocaglaol substrate 6ac was used, we found 
that annulation product 9ac was unexpectedly formed, likely 
though tosyl migration to the primary hydroxyl followed by 
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tosylate extrusion. The structure of 9ac was confirmed using 2D NMR experiments. 1H 
NMR (400 MHz, CDCl3) δ 7.15 – 7.03 (m, 5H), 6.70 – 6.61 (m, 4H), 6.25 (d, J = 1.9 Hz, 
1H), 6.14 (d, J = 1.9 Hz, 1H), 3.93 (s, 3H), 3.83 (s, 3H), 3.75 (dd, J = 14.0, 4.5 Hz, 1H), 
3.71 (s, 3H), 3.21 – 3.05 (m, 3H), 2.07 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 164.0, 160.4, 
159.1, 158.7, 156.1, 134.3, 128.9, 128.6, 128.0, 127.3, 126.3, 112.6, 108.5, 100.1, 93.5, 
91.1, 90.0, 84.6, 56.3, 55.7 55.1, 52.0, 42.5, 41.0, 36.3, 18.8. Purified by HPLC 
(water:MeCN = 90:10 to 5:95 over 10 min (0.01% formic acid additive), flow rate = 25 




carboxylate (Mesyl-enol rocaglate). 
Mesyl-enol rocaglate was synthesized using the same protocol as tosyl-enol rocaglate 
(6a, cf. S4) except using mesyl instead of tosyl chloride. 1H NMR (400 MHz, CDCl3) δ 
7.16 – 6.98 (m, 7H), 6.56 (d, J = 9.0 Hz, 2H), 6.21 (d, J = 2.0 Hz, 1H), 6.04 (d, J = 2.0 Hz, 
1H), 4.64 (s, 1H), 3.81 (s, 3H), 3.79 (s, 3H), 3.66 (s, 6H), 3.53 (s, 3H), 2.99 (s, 1H). 13C 
NMR (101 MHz, CDCl3) δ 163.9, 162.9, 161.2, 158.8, 158.0, 153.3, 137.2, 129.1, 128.9, 
128.1, 127.1, 126.2, 125.1, 112.3, 105.2, 99.7, 92.5, 89.9, 89.1, 58.5, 55.7, 55.3, 55.0, 51.9, 
40.3. Eluent: EA:Hex = 1:1 (Rf = 0.5). ESI MS m/z: 569.4, [M+H]+.  
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2.5 General Method for the Syntheses of Amino-Rocaglate: 
Method A (when amine hydrochloride salts are used): 
 
 Note: while this operation is not strictly necessary, pre-reaction azeotropic drying of 
the amine salt using toluene (high vacuum) is recommended to improve the yield of amino-
rocaglates.  
 To an oven-dried reaction vessel with amine salt (3.0 equiv), NaH (8.0 equiv), and a 
stir bar, anhydrous THF was added at room temperature under nitrogen. After stirring the 
mixture for 30-60 min, a solution of tosyl-enol rocaglate (6a, 1.0 equiv) in THF was added 
at -78 oC at an overall reaction concentration of 0.2 M in 6a. The reaction mixture was 
stirred at -78 oC for an additional 30 min before being warmed to room temperature. The 
reaction was not monitored by TLC for completion; 6a was typically consumed in 15 min 
at room temperature and reactions were typically allowed to progress for 1 h. 
After the completion of the reaction, sat. aq. ammonium chloride was added at -78 oC. 
The crude product was obtained through extraction with ethyl acetate, drying with Na2SO4, 
and concentration in vacuo. Flash chromatography, HPLC, or preparative TLC was utilized 
to offer pure amino-rocaglates. 
Method B (when free-based amines are used): 
 
 To an oven-dried reaction vessel containing NaH (5.0 equiv) and a stir bar was added 
THF followed by addition of amine (3.0 equiv) as a liquid via syringe at room temperature 
under nitrogen. When the amine was a solid, it was pre-mixed with NaH in a reaction vial 
and anhydrous THF was added under nitrogen at room temperature. After stirring the 
reaction mixture for 30-60 min, the tosyl-enol rocaglate (6a, 1.0 equiv) solution in THF 
was added at -78 oC, and the overall reaction concentration is 0.2 M to 6a. The reaction 
mixture was stirred at -78 oC for an additional 30 min before being warmed to room 
temperature. The reaction was not monitored by TLC analysis for completion in which case 
6a was typically consumed in 15 min at room temperature. Reactions were typically 
quenched after stirring at room temperature for 1 h. 
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After the completion of the reaction, sat. aq. ammonium chloride was added at -78 oC. 
The crude product was obtained through extraction with ethyl acetate, drying with Na2SO4, 
and concentration. Flash chromatography, HPLC or preparative TLC was utilized to afford 
pure amino-rocaglate derivatives. 
2.6 Characterization of Amino-Rocaglates: 
 
Typically, amino-rocaglates 15 were found to tautomerize between the keto (major) 
and enol (minor) forms. In this section, we only report the NMR signals of the keto form. 
Of note, we have annotated NMR signals from the enol form of 15a in the 1H NMR 
spectrum as an example (cf. page S104). However, we do not annotate NMR signals for 





1H NMR (500 MHz, CDCl3) δ 7.10 – 7.03 (m, 5H), 6.88 – 
6.84 (m, 2H), 6.64 (d, J = 8.6 Hz, 2H), 6.32 (d, J = 2.0 Hz, 
1H), 6.11 (d, J = 2.0 Hz, 1H), 4.23 (d, J = 13.8 Hz, 1H), 4.02 (d, J = 13.8 Hz, 1H), 3.86 (s, 
3H), 3.80 (s, 3H), 3.71 (s, 3H), 3.63 (s, 3H), 3.03 (s, 3H), 2.96 – 2.90 (m, 2H), 2.04 (ddd, 
J = 12.0, 6.9, 5.9 Hz, 1H), 1.70 (dt, J = 12.0, 4.8 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 
202.8, 167.7, 163.9, 160.1, 158.9, 158.6, 135.6, 128.0, 127.79, 127.77, 127.0, 126.7, 112.5, 
104.3, 98.3, 92.6, 89.4, 79.4, 71.7, 58.0, 56.9, 55.63, 55.62, 55.1, 52.9, 52.8, 40.9. Eluent: 





1H NMR (500 MHz, CDCl3) δ 7.10 – 7.03 (m, 5H), 6.89 – 
6.85 (m, 2H), 6.65 (d, J = 8.4 Hz, 2H), 6.32 (d, J = 2.0 Hz, 
1H), 6.10 (d, J = 2.0 Hz, 1H), 4.23 (d, J = 13.8 Hz, 1H), 4.02 (d, J = 13.8 Hz, 1H), 3.85 (s, 
3H), 3.78 (s, 3H), 3.70 (s, 3H), 3.63 (s, 3H), 2.11 – 1.97 (m, 1H), 1.94 – 1.77 (m, 2H), 1.87 
(s, 6H), 1.65 (dt, J = 11.4, 5.6 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 202.8, 167.8, 163.9, 
160.1, 158.9, 158.6, 135.6, 127.9, 127.8, 127.7, 126.9, 126.8, 112.6, 104.2, 98.3, 92.5, 89.4, 
79.5, 58.6, 56.9, 55.6, 55.5, 55.1, 52.8, 52.8, 44.7, 38.9. Eluent: 8% MeOH in CH2Cl2 (Rf 
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1H NMR (500 MHz, CDCl3) δ 7.11 – 7.04 (m, 3H), 6.98 (d, 
J = 7.7 Hz, 2H), 6.88 – 6.81 (m, 2H), 6.76 (s, 2H), 6.36 (d, 
J = 2.0 Hz, 1H), 6.13 (d, J = 2.0 Hz, 1H), 4.24 (d, J = 13.3 Hz, 1H), 4.03 (d, J = 13.3 Hz, 
1H), 3.87 (s, 3H), 3.79 (s, 3H), 3.74 (s, 3H), 3.64 (s, 3H), 2.65 (ddd, J = 13.7, 7.1, 3.4 Hz, 
1H), 2.59 (dt, J = 12.5, 3.5 Hz, 1H), 2.27 (ddd, J = 11.1, 6.9, 3.6 Hz, 1H), 1.97 (ddd, J = 
13.5, 6.5, 3.4 Hz, 1H), 1.92 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 202.3, 167.2, 164.6, 
160.1, 159.2, 158.8, 135.1, 128.8, 128.0, 127.7, 127.3, 126.4, 113.7, 102.8, 99.0, 92.9, 90.1, 
79.4, 56.3, 55.76, 55.73, 55.4, 53.0, 52.9, 48.9, 38.3, 32.3. Eluent: 8% MeOH in CH2Cl2 





1H NMR (500 MHz, CDCl3) δ 7.10 – 7.04 (m, 5H), 6.93 – 
6.84 (m, 2H), 6.64 (d, J = 8.7 Hz, 2H), 6.33 (d, J = 2.0 Hz, 
1H), 6.12 (d, J = 2.0 Hz, 1H), 5.34 (dddd, J = 17.0, 10.1, 6.7, 5.2 Hz, 1H), 4.79 – 4.68 (m, 
2H), 4.24 (d, J = 13.8 Hz, 1H), 4.04 (d, J = 13.8 Hz, 1H), 3.87 (s, 3H), 3.80 (s, 3H), 3.71 
(s, 3H), 3.64 (s, 3H), 2.42 (ddt, J = 13.5, 6.8, 1.2 Hz, 1H), 2.25 (ddt, J = 13.6, 5.3, 1.7 Hz, 
1H). 13C NMR (126 MHz, CDCl3) δ 203.0, 167.7, 163.9, 160.2, 158.9, 158.6, 136.4, 135.6, 
128.0, 127.80, 127.78, 127.0, 126.6, 115.0, 112.5, 104.3, 98.4, 92.6, 89.5, 79.4, 57.0, 55.6, 





1H NMR (400 MHz, CDCl3) δ 7.10 – 7.01 (m, 5H), 6.88 – 
6.79 (m, 2H), 6.66 (d, J = 8.5 Hz, 2H), 6.33 (d, J = 2.0 Hz, 
1H), 6.11 (d, J = 2.0 Hz, 1H), 4.22 (d, J = 13.8 Hz, 1H), 4.03 
(d, J = 13.8 Hz, 1H), 3.87 (s, 3H), 3.81 (s, 3H), 3.72 (s, 3H), 3.64 (s, 3H), 2.60 (dd, J = 
16.3, 2.5 Hz, 1H), 2.50 (dd, J = 16.3, 2.6 Hz, 1H), 1.89 (t, J = 2.4 Hz, 1H). 13C NMR (126 
MHz, CDCl3) δ 202.1, 167.5, 164.3, 160.2, 159.2, 158.7, 135.3, 127.9, 127.8, 127.7, 127.1, 
126.1, 112.8, 103.3, 98.2, 92.7, 89.5, 81.7, 78.8, 70.3, 56.9, 55.7, 55.6, 55.1, 53.0, 52.9, 








1H NMR (500 MHz, CDCl3) δ 7.10 – 7.02 (m, 5H), 6.89 
– 6.84 (m, 2H), 6.64 (d, J = 8.7 Hz, 2H), 6.32 (d, J = 2.0 
Hz, 1H), 6.11 (d, J = 2.0 Hz, 1H), 4.22 (d, J = 13.8 Hz, 
1H), 4.03 (d, J = 13.8 Hz, 1H), 3.94 (t, J = 5.3 Hz, 1H), 3.86 (s, 3H), 3.79 (s, 3H), 3.71 (s, 
3H), 3.63 (s, 3H), 3.12 (s, 3H), 3.11 (s, 3H), 1.85 (dt, J = 11.2, 5.5 Hz, 1H), 1.56 – 1.48 (m, 
1H), 1.24 – 1.15 (m, 1H), 1.09 – 0.97 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 203.2, 167.7, 
163.8, 160.1, 158.9, 158.6, 135.6, 127.9, 127.79, 127.77, 126.9, 126.7, 112.5, 104.4, 104.0, 
92.5, 89.4, 79.6, 56.9, 55.63, 55.60, 55.0, 52.9, 52.8, 52.6, 52.0, 41.4, 29.7, 24.9. Eluent: 





1H NMR (400 MHz, CDCl3) δ 7.15 – 7.00 (m, 5H), 6.92 – 
6.82 (m, 2H), 6.67 (d, J = 8.8 Hz, 2H), 6.35 (d, J = 2.0 Hz, 
1H), 6.13 (d, J = 2.0 Hz, 1H), 4.25 (d, J = 13.7 Hz, 1H), 4.04 (d, J = 13.7 Hz, 1H), 3.87 (s, 
3H), 3.80 (s, 3H), 3.72 (s, 3H), 3.64 (s, 3H), 1.59 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
203.2, 167.7, 163.9, 160.3, 159.0, 158.6, 135.6, 127.9, 127.8, 127.4, 126.9, 126.7, 112.7, 
103.6, 98.4, 92.5, 89.4, 80.1, 56.9, 55.6, 55.6, 55.1, 52.8, 52.8, 28.5. Eluent: EA:Hex = 1:1 





1H NMR (500 MHz, CDCl3) δ 7.15 (d, J = 8.8 Hz, 2H), 7.13 
– 7.07 (m, 6H), 6.93 – 6.89 (m, 2H), 6.76 – 6.72 (m, 2H), 
6.69 (d, J = 8.3 Hz, 2H), 6.38 (d, J = 2.0 Hz, 1H), 6.15 (d, J = 2.0 Hz, 1H), 4.29 (d, J = 
13.8 Hz, 1H), 4.08 (d, J = 13.9 Hz, 1H), 3.89 (s, 3H), 3.80 (s, 3H), 3.73 (s, 3H), 3.65 (s, 
3H), 2.86 (d, J = 12.2 Hz, 1H), 2.78 (d, J = 12.1 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 
202.8, 167.7, 164.0, 160.2, 158.9, 158.7, 139.9, 135.6, 128.3, 128.0, 127.93, 127.89, 127.8, 
127.0, 126.7, 126.6, 112.7, 104.2, 98.5, 92.6, 89.5, 79.5, 57.0, 57.0, 55.7, 55.6, 53.1, 52.8, 







1H NMR (500 MHz, CDCl3) δ 7.10 – 7.03 (m, 5H), 6.89 – 
6.84 (m, 2H), 6.64 (d, J = 8.1 Hz, 2H), 6.32 (d, J = 1.8 Hz, 
1H), 6.11 (d, J = 1.9 Hz, 1H), 4.22 (d, J = 13.8 Hz, 1H), 4.02 (d, J = 13.6 Hz, 1H), 3.86 (s, 
3H), 3.79 (s, 3H), 3.71 (s, 3H), 3.63 (s, 3H), 1.84 – 1.73 (m, 1H), 1.59 – 1.47 (m, 1H), 1.02 
– 0.79 (m, 7H). 13C NMR (126 MHz, CDCl3) δ 203.3, 167.8, 163.7, 160.1, 158.9, 158.5, 
135.7, 128.0, 127.8, 127.7, 126.9, 126.8, 112.5, 104.5, 98.4, 92.5, 89.4, 79.7, 57.0, 55.63, 
55.59, 55.1, 52.9, 52.8, 41.1, 31.9, 19.8, 13.6. Eluent: EA:Hex = 1:1 (Rf = 0.3). ESI MS 





1H NMR (500 MHz, CDCl3) δ 7.09 – 7.04 (m, 3H), 7.02 – 
6.97 (m, 2H), 6.89 – 6.84 (m, 2H), 6.69 – 6.61 (m, 2H), 6.35 
(d, J = 2.0 Hz, 1H), 6.10 (d, J = 2.0 Hz, 1H), 4.21 (d, J = 13.7 Hz, 1H), 4.01 (d, J = 13.7 
Hz, 1H), 3.87 (s, 3H), 3.79 (s, 3H), 3.71 (s, 3H), 3.63 (s, 3H), 2.09 (hept, J = 6.7 Hz, 1H), 
0.59 (d, J = 6.3 Hz, 3H), 0.15 (d, J = 6.4 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ 203.3, 
167.8, 163.9, 160.1, 159.1, 158.4, 135.8, 128.1, 128.0, 127.8, 127.4, 126.9, 112.5, 105.3, 
99.0, 92.5, 89.7, 80.1, 56.6, 55.6, 55.5, 55.1, 52.79, 52.75, 43.6, 24.2, 24.1. Eluent: EA:Hex 





1H NMR (400 MHz, C6D6) δ 7.23 (bs, 2H), 6.98 – 6.91 (m, 
2H), 6.91 – 6.80 (m, 3H), 6.69 (bs, 1H), 6.48 (bs, 1H), 6.40 
(d, J = 2.1 Hz, 1H), 6.08 (d, J = 2.1 Hz, 1H), 4.67 (d, J = 14.0 Hz, 1H), 4.24 (d, J = 13.9 
Hz, 1H), 3.34 (s, 3H), 3.28 (s, 3H), 3.13 (s, 3H), 3.03 (s, 3H), 2.74 (bs, 1H), 1.66 (d, J = 
3.4 Hz, 3H), 1.56 – 1.41 (m, 3H), 1.25 (s, 6H), 1.19 (dt, J = 11.7, 3.3 Hz, 3H). 13C NMR 
(126 MHz, CDCl3) δ 203.4, 167.9, 164.1, 160.0, 159.7, 158.2, 136.1, 128.9, 128.3, 128.0, 
127.7, 126.8, 112.8, 111.6, 107.5, 99.0, 92.6, 89.8, 78.7, 56.4, 55.6, 55.4, 55.1, 52.7, 52.5, 





1H NMR (500 MHz, CDCl3) δ 7.14 – 7.07 (m, 3H), 7.02 (d, 
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J = 8.9 Hz, 2H), 6.90 – 6.85 (m, 2H), 6.80 (dd, J = 8.5, 7.2 Hz, 2H), 6.60 (d, J = 8.9 Hz, 
2H), 6.54 (t, J = 7.3 Hz, 1H), 6.35 (d, J = 7.7 Hz, 2H), 6.29 (d, J = 2.0 Hz, 1H), 5.87 (d, J 
= 2.0 Hz, 1H), 5.02 (s, 1H), 4.29 (d, J = 13.6 Hz, 1H), 4.07 (d, J = 13.6 Hz, 1H), 3.78 (s, 
3H), 3.66 (s, 3H), 3.65 (s, 3H), 3.63 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 203.2, 167.3, 
164.1, 161.0, 158.6, 158.3, 144.0, 135.6, 128.1, 128.0, 127.9, 127.6, 127.1, 126.8, 119.4, 
117.5, 112.9, 103.5, 98.2, 92.8, 89.2, 79.9, 56.4, 55.5, 55.0, 53.42, 53.37, 52.9. Eluent: 





1H NMR (500 MHz, CDCl3) δ 7.12 – 7.05 (m, 3H), 7.02 (d, 
J = 9.0 Hz, 2H), 6.89 – 6.84 (m, 2H), 6.63 (d, J = 8.4 Hz, 
2H), 6.34 (d, J = 2.0 Hz, 1H), 6.11 (d, J = 2.0 Hz, 1H), 4.22 
(d, J = 13.8 Hz, 1H), 4.03 (d, J = 13.7 Hz, 1H), 3.87 (s, 3H), 3.79 (s, 3H), 3.73 – 3.60 (m, 
2H), 3.70 (s, 3H), 3.64 (s, 3H), 3.11 (dtd, J = 16.8, 11.6, 2.2 Hz, 2H), 2.16 (bs, 1H), 1.72 
(dd, J = 11.1, 5.2 Hz, 1H), 1.41 (dd, J = 11.1, 7.6 Hz, 1H), 1.23 – 1.09 (m, 3H), 0.92 – 0.80 
(m, 1H), 0.60 – 0.47 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 203.3, 167.7, 163.8, 160.0, 
158.8, 158.6, 135.6, 127.9, 127.81, 127.79, 127.0, 126.7, 112.5, 104.3, 98.5, 92.5, 89.5, 
79.5, 67.7, 67.6, 56.9, 55.64, 55.61, 55.1, 52.9, 52.8, 47.8, 35.3, 30.9, 30.8. Eluent: EA:Hex 





1H NMR (500 MHz, CDCl3) δ 7.13 – 7.00 (m, 5H), 6.92 – 
6.80 (m, 2H), 6.65 (d, J = 8.3 Hz, 2H), 6.33 (d, J = 2.0 Hz, 
1H), 6.10 (d, J = 1.8 Hz, 1H), 4.23 (d, J = 13.7 Hz, 1H), 4.03 
(d, J = 13.6 Hz, 1H), 3.86 (s, 3H), 3.77 (s, 3H), 3.71 (s, 3H), 
3.64 (s, 3H), 3.58 – 3.45 (m, 4H), 2.11 – 2.01 (m, 3H), 1.99 
(s, 1H), 1.96 – 1.84 (m, 3H), 1.73 – 1.62 (m, 1H). 13C NMR (126 MHz, CDCl3) δ 203.0, 
167.7, 163.9, 160.1, 158.8, 158.6, 135.6, 127.9, 127.8, 127.5, 127.0, 126.8, 112.7, 104.3, 
98.5, 92.6, 89.5, 79.5, 66.9, 57.7, 56.9, 55.6, 55.5, 55.1, 53.0, 52.8, 52.7, 37.5. Eluent: 3% 







1H NMR (500 MHz, CDCl3) δ 8.41 (s, 1H), 7.10 – 7.04 (m, 
5H), 7.01 (d, J = 9.0 Hz, 2H), 6.88 – 6.83 (m, 2H), 6.60 (d, 
J = 8.8 Hz, 2H), 6.32 (d, J = 2.0 Hz, 1H), 6.10 (d, J = 2.0 
Hz, 1H), 4.22 (d, J = 13.8 Hz, 1H), 4.02 (d, J = 13.8 Hz, 1H), 
3.86 (s, 3H), 3.75 (s, 3H), 3.73 (s, 3H), 3.63 (s, 3H), 2.33 
(hept, J = 7.1 Hz, 2H), 2.13 – 2.06 (m, 1H), 2.05 (s, 3H), 1.81 (dt, J = 11.5, 7.0 Hz, 1H). 
13C NMR (126 MHz, CDCl3) δ 203.0, 167.6, 163.9, 160.1, 158.8, 158.6, 149.0, 148.9, 
135.5, 128.9, 127.9, 127.8, 127.7, 127.0, 126.5, 112.6, 104.1, 98.4, 92.6, 89.5, 79.4, 56.9, 
55.63, 55.59, 55.1, 52.9, 52.8, 43.2, 26.8, 14.5. Eluent: EA:Hex = 2:1 (Rf = 0.1). ESI MS 





1H NMR (500 MHz, CDCl3) δ 7.11 – 7.04 (m, 5H), 6.94 – 
6.86 (m, 2H), 6.76 (d, J = 1.2 Hz, 1H), 6.66 (d, J = 8.6 Hz, 
2H), 6.57 (d, J = 1.3 Hz, 1H), 6.37 (d, J = 2.0 Hz, 1H), 6.15 
(d, J = 2.0 Hz, 1H), 4.30 (d, J = 13.4 Hz, 1H), 4.07 (d, J = 
13.4 Hz, 1H), 3.87 (s, 3H), 3.82 (s, 3H), 3.70 (s, 3H), 3.64 (s, 3H), 3.13 (d, J = 12.5 Hz, 
1H), 2.80 (bs, 1H), 2.74 (s, 3H), 2.58 (bs, 1H). 13C NMR (126 MHz, CDCl3) δ 202.2, 167.5, 
164.3, 160.0, 159.0, 158.8, 145.8, 135.4, 127.93, 127.86, 127.83, 127.0, 126.91, 126.86, 
121.1, 112.9, 103.5, 98.9, 92.7, 89.9, 79.4, 56.8, 55.72, 55.68, 55.2, 52.91, 52.87, 38.9, 





1H NMR (500 MHz, CDCl3) δ 8.32 (t, J = 3.2 Hz, 1H), 7.97 
(s, 1H), 7.12 – 7.07 (m, 5H), 7.00 – 6.96 (m, 2H), 6.92 – 
6.87 (m, 2H), 6.68 (d, J = 8.7 Hz, 2H), 6.38 (d, J = 2.1 Hz, 
1H), 6.14 (d, J = 2.1 Hz, 1H), 4.28 (d, J = 13.7 Hz, 1H), 4.08 
(d, J = 13.7 Hz, 1H), 3.89 (s, 3H), 3.81 (s, 3H), 3.73 (s, 3H), 3.64 (s, 3H), 2.92 (d, J = 12.7 
Hz, 1H), 2.80 (d, J = 12.7 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 202.7, 167.6, 164.1, 
160.2, 158.9, 158.8, 149.6, 148.1, 136.0, 135.4, 135.2, 127.93, 127.89, 127.85, 127.1, 126.5, 
122.9, 112.7, 103.9, 98.6, 92.6, 89.7, 79.4, 56.9, 55.68, 55.65, 55.2, 53.1, 52.9, 44.2. Eluent: 







1H NMR (500 MHz, CDCl3) δ 7.11 (d, J = 8.8 Hz, 2H), 7.09 
– 7.03 (m, 3H), 6.94 – 6.88 (m, 2H), 6.62 (d, J = 8.2 Hz, 2H), 
6.31 (s, 1H), 6.12 (s, 1H), 4.17 (d, J = 14.4 Hz, 1H), 4.12 (d, 
J = 14.3 Hz, 1H), 3.86 (s, 3H), 3.79 (s, 3H), 3.71 (s, 3H), 3.66 (s, 3H), 2.58 (bs, 2H), 1.98 
(t, J = 14.0 Hz, 2H), 1.09 (bs, 2H), 0.95 (bs, 2H), 0.51 (t, J = 7.6 Hz, 6H). 13C NMR (126 
MHz, CDCl3) δ 201.3, 168.2, 163.4, 160.3, 159.3, 158.5, 136.0, 128.6, 127.81, 127.75, 
127.72, 126.7, 112.2, 105.5, 99.9, 92.8, 89.6, 83.4, 58.4, 55.6, 55.5, 55.1, 53.4, 52.7, 50.8, 





1H NMR (500 MHz, CDCl3) δ 7.10 – 7.06 (m, 3H), 7.04 (d, 
J = 9.0 Hz, 2H), 6.94 – 6.89 (m, 2H), 6.66 (d, J = 8.9 Hz, 
2H), 6.40 (d, J = 2.0 Hz, 1H), 6.09 (d, J = 2.0 Hz, 1H), 4.23 (d, J = 13.8 Hz, 1H), 4.08 (d, 
J = 13.8 Hz, 1H), 3.86 (s, 3H), 3.80 (s, 3H), 3.70 (s, 3H), 3.64 (s, 3H), 1.66 (s, 6H). 13C 
NMR (126 MHz, CDCl3) δ 202.2, 167.7, 164.0, 160.6, 158.8, 158.3, 135.7, 128.3, 127.9, 
127.8, 127.7, 126.9, 112.5, 104.8, 99.2, 92.4, 90.0, 80.9, 56.9, 55.6, 55.5, 55.1, 52.8, 52.6, 




 To an oven-dried reaction vessel containing 10 mg of NaH (60 wt%, 5.0 equiv), 20 mg 
of tosyl-enol rocaglate 6a (1.0 equiv), and a stir bar, 0.3 mL of anhydrous THF (0.1 M) was 
added at -78 oC. The reaction mixture was warmed to room temperature, 4 μL of MeOH 
(3.0 equiv) was added, and the reaction mixture was stirred for 30-60 min. The reaction 
was monitored by TLC for completion. After reaction completion, sat. aq. ammonium 
chloride was added at -78 oC. The crude product was obtained through extraction with ethyl 
acetate, drying with Na2SO4, and concentration. The crude product was purified with 
preparative TLC (eluent: EA:Hex = 1:2, Rf = 0.4) to afford 7.3 mg (47% yield) of pure 5b. 
Of note, compound 5b was isolated as a pair of enol/keto tautomers; the keto form was 
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found as the major tautomer as evidenced by the NMR signals below (cf. Page S132). 1H 
NMR (400 MHz, CDCl3) δ 7.16 – 6.95 (m, 5H), 6.83 – 6.77 (m, 2H), 6.67 (d, J = 8.4 Hz, 
2H), 6.36 (d, J = 2.0 Hz, 1H), 6.16 (d, J = 2.0 Hz, 1H), 4.08 (d, J = 13.9 Hz, 1H), 3.99 (d, 
J = 13.8 Hz, 1H), 3.88 (s, 3H), 3.84 (s, 3H), 3.74 (s, 3H), 3.63 (s, 3H), 2.65 (s, 3H). 13C 
NMR (101 MHz, CDCl3) δ 200.5, 167.5, 165.2, 161.9, 159.8, 158.9, 135.1, 128.0, 127.9, 
127.4, 127.2, 125.8, 113.1, 101.2, 97.8, 92.8, 89.5, 56.5, 55.8, 55.7, 55.1, 52.8, 52.2, 51.5. 
ESI MS m/z: 505.3, [M+H]+. 





 To a 4 mL vial with 24 mg of 15a (1.0 equiv), 0.2 mg DMAP (0.4 equiv), 15.8 mg 
benzamidine (3.0 equiv), and a stir bar was added 1.75 mL of m-xylene (0.025M) at room 
temperature under nitrogen. The reaction vial was placed onto a pre-heated heating block 
at 130 oC and was stirred for 45 min. The reaction was quenched with sat. aq. ammonium 
chloride, and the crude product was obtained by extraction with ethyl acetate, drying with 
Na2SO4, and concentration. Purification by preparative TLC (eluent: 10% acetone in 
CH2Cl2, Rf = 0.6) was used to afford 17.3 mg (64% yield) of 16 as a pale yellow solid. 
1H 
NMR (400 MHz, DMSO-d6) δ 8.21 (d, J = 7.0 Hz, 2H), 7.67 – 7.55 (m, 3H), 7.07 – 6.96 
(m, 4H), 6.87 – 6.80 (m, 2H), 6.51 (d, J = 9.0 Hz, 2H), 6.39 (d, J = 2.0 Hz, 1H), 6.17 (d, J 
= 2.0 Hz, 1H), 4.45 (s, 1H), 3.78 (s, 3H), 3.78 (s, 3H), 3.56 (s, 3H), 2.96 (s, 3H), 2.74 (t, J 
= 6.8 Hz, 2H), 2.11 (dt, J = 12.8, 6.8 Hz, 1H), 1.33 (bs, 1H). 13C NMR (101 MHz, DMSO-
d6) δ 168.0, 163.1, 160.5, 160., 158.4, 158.3, 158.2, 136.9, 132.7, 132.3, 129.6, 129.2, 128.4, 
128.1, 127.4, 126.5, 120.5, 111.8, 106.0, 103.4, 92.8, 89.5, 78.7, 71.7, 59.8, 57.8, 56.1, 







 To a 4 mL vial containing 14.5 mg of 15a (1.0 equiv), 1 mg of DMAP (0.3 equiv), and 
a stir bar was added 0.5 mL of toluene (0.05 M) followed by 0.13 mL of a THF solution of 
dimethylamine (2.0 M, 10.0 equiv). The reaction mixture was heated to 90 oC for 3 h. After 
reaction completion, sat. aq. ammonium chloride was added at room temperature to quench 
the reaction. The crude product was obtained through extraction with ethyl acetate, drying 
with Na2SO4, and concentration. Filtration through a silica gel plug was followed by 
concentration which afforded 13.8 mg (92% yield) of amino-rocaglamide derivative 17 as 
a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.14 (d, J = 8.2 Hz, 2H), 7.08 – 7.02 (m, 3H), 
6.82 – 6.78 (m, 2H), 6.67 (d, J = 8.3 Hz, 2H), 6.30 (d, J = 2.0 Hz, 1H), 6.08 (d, J = 2.0 Hz, 
1H), 4.50 (d, J = 13.5 Hz, 1H), 4.32 (d, J = 13.6 Hz, 1H), 3.83 (s, 3H), 3.78 (s, 3H), 3.73 
(s, 3H), 3.23 (s, 3H), 3.04 (s, 3H), 2.93 (dd, J = 7.5, 4.6 Hz, 2H), 2.89 (s, 3H), 2.07 – 2.00 
(m, 1H), 1.66 (dt, J = 12.1, 4.5 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 205.2, 165.6, 163.7, 
160.1, 158.8, 158.5, 136.3, 128.1, 127.9, 127.7, 127.4, 126.7, 112.5, 104.2, 98.0, 92.6, 89.3, 
79.4, 71.8, 58.0, 55.60, 55.58, 55.1, 54.2, 52.9, 40.9, 37.6, 36.1. Eluent: EA:Hex = 1:1, Rf 





 To a 4 mL vial containing 35 mg of 17 (1.0 equiv) and a stir bar was added 0.5 mL of 
THF under nitrogen. The reaction was cooled to -78 oC which was followed by the addition 
of 0.13 mL H3B·SMe2 THF solution (1.0 M, 2.0 equiv). The reaction was warmed to room 
temperature and was stirred for 24 h. The reaction was quenched with sat. aq. ammonium 
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chloride at room temperature. The crude product was obtained through extraction with 
ethyl acetate, drying with Na2SO4, and concentration. After a preparative TLC (eluent: 3% 
MeOH in CH2Cl2, Rf = 0.4), 10.9 mg 18 was obtained as a white solid (31% yield) along 
with recovered starting material 17 (13.6 mg, 38% yield). 1H NMR (400 MHz, CDCl3) δ 
7.39 – 7.20 (m, 2H), 7.05 – 6.96 (m, 3H), 6.84 – 6.68 (m, 4H), 6.26 (d, J = 2.0 Hz, 1H), 
6.08 (d, J = 2.0 Hz, 1H), 4.77 (d, J = 6.8 Hz, 1H), 4.04 (d, J = 13.4 Hz, 1H), 3.84 (s, 3H), 
3.81 (s, 3H), 3.78 – 3.75 (m, 1H), 3.74 (s, 3H), 3.29 (s, 3H), 3.17 – 3.07 (bs, 1H), 2.98 (dt, 
J = 9.9, 4.7 Hz, 1H), 2.92 (s, 3H), 2.87 (s, 3H), 2.19 – 2.11 (m, 1H), 2.05 (ddd, J = 11.9, 
7.4, 3.9 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 172.0, 163.2, 159.4, 158.5, 157.8, 137.0, 
128.4, 128.1, 127.5, 126.3, 113.1, 109.5, 102.3, 92.2, 89.4, 74.1, 71.8, 57.8, 55.6, 55.4, 




 To a 4 mL vial containing 11.2 mg of 15a (1.0 equiv), 1.0 mg DMAP (0.4 equiv), and 
a stir bar was added 0.4 mL of toluene followed by a drop of DI water. The reaction was 
heated to 90 oC for 3 h. The reaction mixture was concentrated to yield the crude product. 
10 mg of amino-ketone 19 (quantitative yield) was obtained after filtration through a silica 
gel plug (eluent: EA:Hex = 1:1, Rf = 0.4). 
1H NMR (500 MHz, CDCl3) δ 7.16 – 7.02 (m, 
5H), 6.94 – 6.83 (m, 2H), 6.64 (d, J = 8.7 Hz, 2H), 6.32 (d, J = 2.0 Hz, 1H), 6.11 (d, J = 
2.0 Hz, 1H), 3.89 – 3.83 (m, 1H), 3.85 (s, 3H), 3.82 (s, 3H), 3.71 (s, 3H), 3.02 (s, 3H), 2.97 
– 2.89 (m, 4H), 2.03 (dt, J = 12.4, 6.3 Hz, 1H), 1.71 (dt, J = 12.1, 4.9 Hz, 1H). 13C NMR 
(126 MHz, CDCl3) δ 209.9, 163.7, 160.3, 158.8, 158.4, 137.4, 128.1, 127.68, 127.67, 127.1, 
126.6, 112.5, 104.7, 100.5, 92.2, 89.3, 71.9, 58.0, 55.6, 55.5, 551, 49.5, 41.0, 40.5. ESI MS 




To a 4 mL vial containing 10 mg of 19 (1.0 equiv) and a stir bar was added 1.0 mL of 
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MeOH (0.02M) at room temperature. 15.5 mg of solid NaBH4 (20 equiv) was added 
batchwise. The reaction slurry was stirred overnight, and was checked for completion using 
TLC analysis (eluent: EA:Hex = 1:1, Rf = 0.2). The reaction was quenched with sat. aq. 
ammonium chloride, extracted with ethyl acetate, dried with Na2SO4, and concentrated in 
vacuo to afford the crude product which was purified using preparative TLC. 7.1 mg (71% 
yield) of the desired product 20 was obtained as a white solid. 1H NMR (500 MHz, CDCl3) 
δ 7.28 (d, J = 7.9 Hz, 2H), 7.10 – 6.99 (m, 3H), 6.95 – 6.89 (m, 2H), 6.70 (d, J = 8.2 Hz, 
2H), 6.28 (d, J = 2.0 Hz, 1H), 6.12 (d, J = 2.0 Hz, 1H), 4.85 (t, J = 7.5 Hz, 1H), 3.86 (s, 
3H), 3.85 (s, 3H), 3.72 (s, 3H), 3.48 (dd, J = 14.6, 7.1 Hz, 1H), 3.10 (ddd, J = 10.1, 7.2, 4.6 
Hz, 1H), 2.96 (dt, J = 9.9, 4.8 Hz, 1H), 2.91 (s, 3H), 2.57 (dt, J = 13.6, 7.4 Hz, 1H), 2.29 
(td, J = 14.1, 7.3 Hz, 1H), 2.11 – 2.01 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 163.1, 159.5, 
158.3, 157.9, 138.5, 128.3, 128.1, 127.5, 126.1, 112.9, 109.7, 102.7, 91.9, 89.3, 75.5, 72.2, 
71.9, 57.8, 55.6, 55.4, 55.1, 50.4, 41.4, 36.9. ESI MS m/z: 492.4, [M+H]+. 
 
(3S,3aR,8bS,E)-6,8-Dimethoxy-8b-((2-methoxyethyl)amino)-3a-(4-methoxyphenyl)-
3-phenyl-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-1-one oxime (21) 
 To a 4 mL vial containing 14.2 mg of NH2OH·HCl (5.0 equiv) and a stir bar was added 
0.2 mL of MeOH at room temperature which was followed by addition of 20 μL of 
triethylamine (3.5 equiv). After stirring at room temperature for 30 min, 20 mg of 19 (1.0 
equiv) in 0.2 mL MeOH was added; the overall concentration for 19 was 0.1 M. The 
reaction was heated to 37 oC and stirred for 36 h. Once the reaction turned from a clear 
solution to a white slurry, TLC analysis was used to check for reaction completion. The 
reaction was concentrated which was followed by addition ethyl acetate and sat. aq. 
ammonium chloride. After extraction, drying with Na2SO4, and concentration, crude 
product was obtained. Flash chromatography (eluent: EA:Hex = 1:1, Rf = 0.3) was utilized 
to purify the crude product to afford 17.9 mg (82% yield) of the desired oxime product 21 
as a white solid. 1H NMR (500 MHz, CDCl3) δ 7.03 (d, J = 8.9 Hz, 2H), 7.02 – 6.97 (m, 
3H), 6.90 – 6.86 (m, 2H), 6.62 (d, J = 8.9 Hz, 2H), 6.24 (d, J = 2.0 Hz, 1H), 6.07 (d, J = 
2.1 Hz, 1H), 3.79 (s, 3H), 3.76 (s, 3H), 3.67 – 3.63 (m, 1H), 3.65 (s, 3H), 3.18 (s, 1H), 3.02 
(dd, J = 11.3, 6.2 Hz, 2H), 2.91 (dt, J = 10.5, 5.4 Hz, 1H), 2.86 (s, 3H), 2.83 (dt, J = 10.5, 
5.4 Hz, 1H), 1.90 (dt, J = 11.0, 5.6 Hz, 1H), 1.81 (dt, J = 11.0, 5.6 Hz, 1H). 13C NMR (126 
MHz, CDCl3) δ 163.2, 161.7, 159.8, 158.9, 158.3, 137.7, 128.0, 127.7, 127.5, 127.1, 126.3, 
112.7, 106.6, 100.9, 92.4, 89.3, 76.3, 71.7, 57.6, 55.5, 55.3, 55.0, 50.8, 40.6, 29.3. ESI MS 






 To a 4 mL reaction vial containing 11 mg of LiAlH4 (5.0 equiv) and a stir bar was 
added 27.1 mg of oxime 21 in 0.6 mL of THF (0.09 M) dropwise under nitrogen at -78 oC. 
The reaction mixture was stirred at -78 oC for an additional 2 h and was then warmed to 
room temperature and stirred for 12 h. Incomplete reaction was found by TLC analysis, 
with no further conversion by adding additional LiAlH4. The reaction was quenched at -78 
oC with sat. aq. ammonium chloride and Rochelle’s salt, and the mixture was stirred for 6 
h. After extraction with ethyl acetate, drying with Na2SO4, and concentration, crude 
product was obtained and, then, was purified using preparative TLC (eluent: 3% MeOH in 
CH2Cl2, Rf = 0.15). 10% MeOH/2% NEt3 in CH2Cl2 was used to elute the product from the 
silica gel. 11 mg (40% yield) of the desired product 22 was isolated as a pale yellow solid. 
Compound 22 was found to be labile and slowly decomposed in CDCl3 solution during an 
overnight NMR experiment. 1H NMR (500 MHz, CDCl3) δ 7.31 (d, J = 6.9 Hz, 1H), 7.09 
– 6.96 (m, 5H), 6.67 (d, J = 6.8 Hz, 1H), 6.25 (d, J = 2.0 Hz, 1H), 6.10 (d, J = 2.0 Hz, 1H), 
4.05 (dd, J = 10.3, 7.7 Hz, 1H), 3.87 (s, 3H), 3.84 (s, 3H), 3.69 (s, 3H), 3.55 (dd, J = 13.7, 
6.8 Hz, 1H), 2.99 (s, 3H), 2.94 (t, J = 5.6 Hz, 2H), 2.62 – 2.46 (m, 2H), 2.05 (dt, J = 11.8, 
5.6 Hz, 1H), 1.72 (dt, J = 11.6, 5.4 Hz, 1H). 13C NMR (126 MHz, CDCl3) δ 162.9, 158.9, 
158.3, 157.3, 138.2, 128.8, 128.1, 128.0, 127.5, 126.1, 112.5, 101.9, 91.8, 88.9, 75.1, 71.9, 




3. Asymmetric Syntheses and Chiral HPLC Traces for Select Compounds: 
3.1 Enantioselective Syntheses of (+)- and (-)-Tosyl-Enol Rocaglates: 
 
According to our biomimetic kinetic resolution strategy,S4 we used a Noyori reduction 
protocol to access the (+) and (-)-keto-aglain derivatives (Scheme SI2). 
 
Subsequent ketol-shift, tosyl protection, recrystallization, and deprotection of the enol 
tosyl protocols have been reported in our previous publication.S5 Compounds (+)-6a and 
(-)-6a were synthesized accordingly (Scheme SI3). (-)-6z was synthesized from an 





Compounds (-)-6aa and (+)-6aa (cf. page S6) were synthesized according to our 
previously reported procedure involving kinetic resolution of keto-aglain Weinreb amide 
substrates (Scheme SI4).S4 Further conversion of these intermediates to (-)-6aa and (+)-
6aa from keto-aglain Weinreb amide substrates used identical protocols to the racemic 
synthesis of 6aa as shown previously. 
3.2 Chiral HPLC Traces for (±)-, (-)-, and (+)-6a: 
A WelkO column was used with an isocratic mobile phase of 40% isopropanol in 









26 = –223.22° (c = 0.05, CH2Cl2): 
 
(+)-6 [α]D





3.3 Chiral HPLC Traces for (±)-, (-)-, and (+)-6aa: 
A WelkO column was used with an isocratic mobile phase of 40% isopropanol in hexanes 









26 = 85.89° (c = 0.1, CH2Cl2): 
 
3.4 Chiral HPLC Traces for (±)- and (-)-15h: 
A ChiralCel OD column was used with an isocratic mobile phase of 10% isopropanol 






26 = –60.18° (c = 0.02, CH2Cl2): 
 
3.6 Optical Rotations for other compounds: 
(-)-6z [α]D
27 = –150.44° (c = 0.01, CH2Cl2) 
(-)-9b [α]D
26 = –80.32° (c = 0.01, CH2Cl2) 
(-)-9e [α]D
26 = –46.17° (c = 0.05, CH2Cl2) 
(-)-9k [α]D
27 = –26.12° (c = 0.05, CH2Cl2) 
(-)-9n [α]D
27 = –32.21° (c = 0.03, CH2Cl2) 
(-)-9z [α]D
26 = –58.49° (c = 0.01, CH2Cl2) 
(-)-9aa [α]D
27 = –22.75° (c = 0.02, CH2Cl2) 
(+)-9aa [α]D






4. X-Ray Crystal Structure Analysis for Amidino-Rocaglate 9a: 
 Crystals of amidino rocaglate 9a suitable for X-ray analysis were obtained by vapor 
diffusion from CDCl3/hexanes. Crystallographic data have been deposited with the 
Cambridge Crystallographic Data Center (CCDC 1909290). Copies of the data can be 
obtained free of charge through application to the CCDC, 12 Union Road, Cambridge 
CB21EZ, UK (fax: +440-1223-336-033; email: deposit@ccdc.cam.ac.uk) 
 
Identification code 9a (CHCl3 solvent was removed) 
Refinement: 




Data collection: APEX3 (Bruker, 2016); cell refinement: SAINT (Bruker, 2006); data 
reduction: SAINT (Bruker, 2006); program(s) used to solve structure: ShelXT (Sheldrick, 
2015); program(s) used to refine structure: SHELXL (Sheldrick, 2015); molecular graphics: 
Olex2 (Dolomanov et al., 2009); software used to prepare material for publication: Olex2 
(Dolomanov et al., 2009). 
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Crystal Data: 
C35H31NO8 F(000) = 2496 
Mr = 593.61 Dx = 1.338 Mg m-3 
Monoclinic, C2/c Cu K radiation,  = 1.54178 Å 
a = 26.6128 (17) Å Cell parameters from 9980 reflections 
b = 10.4020 (7) Å  = 3.3–66.7° 
c = 21.3640 (14) Å  = 0.78 mm-1 
 = 94.776 (4)° T = 100 K 
V = 5893.6 (7) Å3 Prism 





Bruker APEX-II CCD  
diffractometer 
4678 reflections with I > 2(I) 
 and  scans Rint = 0.068 
Absorption correction: multi-scan  
SADABS2016/2 (Bruker,2016/2) was used for 
absorption correction. wR2(int) was 0.0960 
before and 0.0758 after correction. The Ratio of 
minimum to maximum transmission is 0.8247. 
The /2 correction factor is Not present. 
max = 66.6°, min = 3.3° 
Tmin = 0.621, Tmax = 0.753 h = -3131 
33704 measured reflections k = -1212 
5217 independent reflections l = -2125 
Refinement: 
Refinement on F2 Primary atom site location: dual 
Least-squares matrix: full Hydrogen site location: inferred from 
neighbouring sites 
R[F2 > 2(F2)] = 0.069 H-atom parameters constrained 
wR(F2) = 0.161  w = 1/[2(Fo2) + (0.040P)2 + 18.183P]   
where P = (Fo2 + 2Fc2)/3 
S = 1.10 (/)max < 0.001 
5217 reflections max = 0.36 e Å-3 
418 parameters min = -0.41 e Å-3 
1 restraint  
Special Details: 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are 
estimated using the full covariance matrix. The cell esds are taken into account individually 
in the estimation of esds in distances, angles and torsion angles; correlations between esds 
in cell parameters are only used when they are defined by crystal symmetry. An 





Fractional Atomic Coordinates and Isotropic or Equivalent Isotropic Displacement 
Parameters (Å2) for 9a: 
 x y z Uiso*/Ueq Occ. (<1) 
O5 0.59210 (6) 0.37894 (18) 0.23913 (8) 0.0311 (4)  
O4 0.53474 (6) 0.30325 (17) 0.34125 (8) 0.0309 (4)  
H4 0.540313 0.320767 0.305046 0.046*  
O2 0.68580 (7) 0.2831 (2) 0.42509 (8) 0.0416 (5)  
O3 0.62109 (7) 0.54304 (18) 0.36020 (9) 0.0364 (5)  
O7 0.46653 (7) 0.3352 (2) 0.46497 (10) 0.0472 (5)  
O6 0.72816 (8) 0.0834 (2) 0.23268 (9) 0.0486 (6)  
N1 0.53738 (8) 0.5214 (2) 0.36978 (10) 0.0319 (5)  
O8 0.50853 (9) 0.1533 (2) 0.45203 (13) 0.0607 (7)  
O1A 0.71920 (13) 0.7846 (4) 0.59182 (15) 0.0438 (10) 0.779 (6) 
C18 0.55849 (9) 0.3939 (2) 0.38232 (11) 0.0252 (5)  
C11 0.63156 (9) 0.3091 (3) 0.26652 (12) 0.0286 (6)  
C10 0.64096 (9) 0.3242 (3) 0.33144 (12) 0.0281 (5)  
C9 0.61630 (9) 0.4083 (3) 0.37607 (11) 0.0272 (5)  
C20 0.55413 (9) 0.3495 (3) 0.45100 (12) 0.0283 (5)  
H20 0.554517 0.426481 0.477481 0.034*  
C12 0.66196 (9) 0.2274 (3) 0.23493 (12) 0.0336 (6)  
H12 0.656136 0.215996 0.191759 0.040*  
C5A 0.66444 (10) 0.4777 (3) 0.48300 (17) 0.0311 (9) 0.779 (6) 
C6A 0.71449 (10) 0.4747 (3) 0.50745 (14) 0.0363 (10) 0.779 (6) 
H6A 0.734875 0.405323 0.498962 0.044* 0.779 (6) 
C7A 0.73407 (8) 0.5756 (4) 0.54459 (12) 0.0376 (11) 0.779 (6) 
H7A 0.767559 0.573592 0.560953 0.045* 0.779 (6) 
C2A 0.70360 (11) 0.6793 (3) 0.55728 (11) 0.0320 (9) 0.779 (6) 
C3A 0.65355 (11) 0.6822 (3) 0.53283 (13) 0.0326 (8) 0.779 (6) 
H3A 0.633169 0.751632 0.541324 0.039* 0.779 (6) 
C4A 0.63397 (9) 0.5814 (3) 0.49569 (17) 0.0324 (8) 0.779 (6) 
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H4A 0.600484 0.583363 0.479334 0.039* 0.779 (6) 
C15 0.68022 (9) 0.2584 (3) 0.36230 (12) 0.0354 (6)  
C23 0.60339 (9) 0.2767 (3) 0.46743 (12) 0.0311 (6)  
H23 0.601640 0.199165 0.441266 0.037* 0.801 (6) 
H23A 0.602512 0.192707 0.446569 0.037* 0.199 (6) 
C19 0.57344 (11) 0.5944 (3) 0.35823 (12) 0.0351 (6)  
C13 0.70159 (10) 0.1623 (3) 0.26878 (13) 0.0381 (7)  
C8 0.64409 (9) 0.3652 (3) 0.44068 (12) 0.0319 (6)  
C21 0.50518 (10) 0.2804 (3) 0.45751 (13) 0.0376 (7)  
C16 0.58518 (10) 0.3789 (3) 0.17193 (12) 0.0412 (7)  
H16A 0.615250 0.409935 0.155123 0.062*  
H16B 0.557359 0.433721 0.158394 0.062*  
H16C 0.578295 0.292946 0.157240 0.062*  
C14 0.71196 (10) 0.1769 (3) 0.33293 (14) 0.0427 (7)  
H14 0.738649 0.134557 0.354969 0.051*  
C30A 0.61447 (17) 0.2312 (4) 0.53416 (19) 0.0345 (10) 0.801 (6) 
C31A 0.64510 (15) 0.1243 (4) 0.54698 (18) 0.0383 (9) 0.801 (6) 
H31A 0.656605 0.077722 0.513873 0.046* 0.801 (6) 
C24A 0.56193 (14) 0.7318 (3) 0.3417 (3) 0.0315 (12) 0.588 (4) 
C25A 0.60273 (12) 0.8145 (4) 0.3391 (3) 0.0725 (19) 0.588 (4) 
H25A 0.635438 0.782961 0.345845 0.087* 0.588 (4) 
C26A 0.59464 (17) 0.9442 (4) 0.3265 (3) 0.080 (2) 0.588 (4) 
H26A 0.621942 0.999574 0.324738 0.096* 0.588 (4) 
C27A 0.5458 (2) 0.9913 (3) 0.3164 (3) 0.077 (2) 0.588 (4) 
H27A 0.540347 1.078151 0.307935 0.092* 0.588 (4) 
C28A 0.50496 (15) 0.9086 (4) 0.3190 (3) 0.091 (2) 0.588 (4) 
H28A 0.472248 0.940115 0.312239 0.110* 0.588 (4) 
C29A 0.51304 (13) 0.7788 (4) 0.3316 (3) 0.0717 (19) 0.588 (4) 
H29A 0.485743 0.723500 0.333347 0.086* 0.588 (4) 
C35A 0.5972 (2) 0.2969 (5) 0.5845 (2) 0.0524 (13) 0.801 (6) 
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H35A 0.576438 0.368286 0.577228 0.063* 0.801 (6) 
C17 0.77016 (14) 0.0171 (4) 0.26302 (17) 0.0696 (12)  
H17A 0.784778 -0.037823 0.233317 0.104*  
H17B 0.759186 -0.033870 0.296780 0.104*  
H17C 0.794862 0.078266 0.279452 0.104*  
C32A 0.65876 (16) 0.0861 (5) 0.60828 (19) 0.0503 (11) 0.801 (6) 
H32A 0.679941 0.015641 0.615786 0.060* 0.801 (6) 
C1A 0.77125 (15) 0.7919 (6) 0.61427 (19) 0.0516 (14) 0.779 (6) 
H1AA 0.791778 0.780255 0.579820 0.077* 0.779 (6) 
H1AB 0.778822 0.725790 0.644978 0.077* 0.779 (6) 
H1AC 0.778113 0.874520 0.633085 0.077* 0.779 (6) 
C22 0.46080 (16) 0.0856 (4) 0.4532 (3) 0.0858 (15)  
H22A 0.437121 0.119081 0.420958 0.129*  
H22B 0.447841 0.097320 0.493450 0.129*  
H22C 0.465939 -0.004412 0.446070 0.129*  
C34A 0.6106 (2) 0.2570 (6) 0.6461 (2) 0.0702 (18) 0.801 (6) 
H34A 0.598736 0.301831 0.679600 0.084* 0.801 (6) 
C33A 0.6414 (2) 0.1507 (5) 0.6575 (2) 0.0650 (14) 0.801 (6) 
H33A 0.650240 0.123797 0.698421 0.078* 0.801 (6) 
C24B 0.5820 (2) 0.7307 (4) 0.3475 (4) 0.0315 (12) 0.412 (4) 
C25B 0.6239 (2) 0.7875 (5) 0.3243 (4) 0.0725 (19) 0.412 (4) 
H25B 0.651301 0.737125 0.315379 0.087* 0.412 (4) 
C26B 0.6249 (3) 0.9195 (6) 0.3145 (4) 0.080 (2) 0.412 (4) 
H26B 0.653007 0.957500 0.298972 0.096* 0.412 (4) 
C27B 0.5840 (3) 0.9948 (4) 0.3278 (4) 0.077 (2) 0.412 (4) 
H27B 0.584706 1.083123 0.321257 0.092* 0.412 (4) 
C28B 0.5421 (3) 0.9380 (6) 0.3510 (4) 0.091 (2) 0.412 (4) 
H28B 0.514697 0.988373 0.359948 0.110* 0.412 (4) 
C29B 0.5411 (2) 0.8060 (6) 0.3608 (4) 0.0717 (19) 0.412 (4) 
H29B 0.512990 0.767998 0.376355 0.086* 0.412 (4) 
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O1B 0.7494 (5) 0.7159 (12) 0.6008 (5) 0.050 (3) 0.221 (6) 
C1B 0.7357 (8) 0.841 (2) 0.5951 (8) 0.047 (5) 0.221 (6) 
H1BA 0.728208 0.861059 0.551532 0.070* 0.221 (6) 
H1BB 0.762718 0.894071 0.612477 0.070* 0.221 (6) 
H1BC 0.706265 0.855171 0.617332 0.070* 0.221 (6) 
C5B 0.6707 (5) 0.4479 (12) 0.4871 (7) 0.0311 (9) 0.221 (6) 
C6B 0.7188 (4) 0.4223 (11) 0.5149 (6) 0.0363 (10) 0.221 (6) 
H6B 0.734276 0.344266 0.507575 0.044* 0.221 (6) 
C7B 0.7437 (3) 0.5135 (14) 0.5537 (5) 0.0376 (11) 0.221 (6) 
H7B 0.775817 0.496393 0.572273 0.045* 0.221 (6) 
C2B 0.7205 (4) 0.6302 (12) 0.5646 (5) 0.0320 (9) 0.221 (6) 
C3B 0.6725 (5) 0.6557 (11) 0.5368 (6) 0.0326 (8) 0.221 (6) 
H3B 0.656955 0.733768 0.544188 0.039* 0.221 (6) 
C4B 0.6476 (4) 0.5646 (14) 0.4981 (7) 0.0324 (8) 0.221 (6) 
H4B 0.615412 0.581643 0.479489 0.039* 0.221 (6) 
C30B 0.6213 (7) 0.2623 (17) 0.5375 (6) 0.0345 (10) 0.199 (6) 
C35B 0.6019 (7) 0.3298 (18) 0.5862 (8) 0.0524 (13) 0.199 (6) 
H35B 0.576073 0.389130 0.577512 0.063* 0.199 (6) 
C34B 0.6210 (7) 0.3087 (17) 0.6479 (7) 0.0702 (18) 0.199 (6) 
H34B 0.607987 0.353903 0.680466 0.084* 0.199 (6) 
C33B 0.6595 (6) 0.2201 (17) 0.6609 (4) 0.0650 (14) 0.199 (6) 
H33B 0.672338 0.206003 0.702158 0.078* 0.199 (6) 
C32B 0.6790 (5) 0.1526 (15) 0.6122 (5) 0.0503 (11) 0.199 (6) 
H32B 0.704776 0.093329 0.620897 0.060* 0.199 (6) 
C31B 0.6599 (5) 0.1737 (14) 0.5505 (5) 0.0383 (9) 0.199 (6) 





Geometric parameters (Å, º) for 9a: 
O4—C21 1.363 (4) C25—H25 0.9500 
O4—C11 1.463 (4) C7—H7A 1.0000 
O7—H7 0.8400 C29—C30 1.384 (7) 
O7—C35 1.416 (4) C29—C34 1.383 (6) 
O6—C26 1.372 (4) C14—H14 0.9500 
O6—C27 1.429 (5) C14—C13 1.395 (6) 
O2—C9 1.336 (5) C3—H3 0.9500 
O2—C10 1.450 (5) C3—C2 1.387 (6) 
O5—C23 1.369 (4) C13—H13 0.9500 
O5—C24 1.432 (5) C24—H24A 0.9800 
O3—C15 1.385 (4) C24—H24B 0.9800 
O3—C16 1.423 (5) C24—H24C 0.9800 
O1—C9 1.212 (5) C10—H10A 0.9800 
N2—C28 1.290 (5) C10—H10B 0.9800 
N2—C35 1.462 (5) C10—H10C 0.9800 
N1—H1 0.8800 C16—H16A 0.9800 
N1—C19 1.448 (4) C16—H16B 0.9800 
N1—C28 1.358 (5) C16—H16C 0.9800 
C19—C20 1.500 (5) C30—H30 0.9500 
C19—C11 1.588 (5) C30—C31 1.390 (6) 
C19—C35 1.583 (5) C2—H2 0.9500 
C20—C21 1.376 (5) C2—C1 1.380 (7) 
C20—C26 1.384 (5) C5—H5 0.9500 
C28—C29 1.482 (5) C5—C6 1.385 (7) 
C21—C22 1.390 (5) C1—H1A 0.9500 
C12—C11 1.514 (5) C1—C6 1.380 (7) 
C12—C18 1.390 (5) C34—H34 0.9500 
C12—C13 1.382 (5) C34—C33 1.407 (7) 
C11—C7 1.555 (5) C27—H27A 0.9800 
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C26—C25 1.385 (5) C27—H27B 0.9800 
C22—H22 0.9500 C27—H27C 0.9800 
C22—C23 1.376 (5) C6—H6 0.9500 
C15—C17 1.381 (6) C33—H33 0.9500 
C15—C14 1.376 (5) C33—C32 1.373 (9) 
C35—C8 1.547 (5) C31—H31 0.9500 
C8—H8 1.0000 C31—C32 1.365 (9) 
C8—C9 1.503 (5) C32—H32 0.9500 
C8—C7 1.538 (5) Cl1S—C1S 1.792 (5) 
C23—C25 1.408 (5) Cl5S—C1S 1.846 (6) 
C18—H18 0.9500 C1S—H1SA 1.0000 
C18—C17 1.380 (5) C1S—H1S 1.0000 
C4—C7 1.516 (5) C1S—Cl3S 1.753 (6) 
C4—C3 1.392 (5) C1S—Cl4S 1.756 (6) 
C4—C5 1.385 (6) C1S—Cl2S 1.694 (5) 
C17—H17 0.9500 C1S—Cl6S 1.684 (7) 
C21—O4—C11 108.6 (3) C4—C7—C8 116.7 (3) 
C35—O7—H7 109.5 C4—C7—H7A 106.2 
C26—O6—C27 116.1 (3) C30—C29—C28 121.0 (4) 
C9—O2—C10 115.2 (3) C34—C29—C28 119.5 (4) 
C23—O5—C24 116.8 (3) C34—C29—C30 119.4 (4) 
C15—O3—C16 117.4 (3) C15—C14—H14 120.4 
C28—N2—C35 107.0 (3) C15—C14—C13 119.2 (4) 
C19—N1—H1 125.0 C13—C14—H14 120.4 
C28—N1—H1 125.0 C4—C3—H3 119.4 
C28—N1—C19 110.0 (3) C2—C3—C4 121.2 (4) 
N1—C19—C20 114.0 (3) C2—C3—H3 119.4 
N1—C19—C11 116.7 (3) C12—C13—C14 121.7 (4) 
N1—C19—C35 100.3 (3) C12—C13—H13 119.2 
C20—C19—C11 100.9 (3) C14—C13—H13 119.2 
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C20—C19—C35 119.2 (3) O5—C24—H24A 109.5 
C35—C19—C11 106.3 (3) O5—C24—H24B 109.5 
C21—C20—C19 110.1 (3) O5—C24—H24C 109.5 
C21—C20—C26 118.8 (3) H24A—C24—H24B 109.5 
C26—C20—C19 131.0 (3) H24A—C24—H24C 109.5 
N2—C28—N1 116.4 (3) H24B—C24—H24C 109.5 
N2—C28—C29 123.2 (3) O2—C10—H10A 109.5 
N1—C28—C29 120.4 (3) O2—C10—H10B 109.5 
O4—C21—C20 113.6 (3) O2—C10—H10C 109.5 
O4—C21—C22 122.5 (3) H10A—C10—H10B 109.5 
C20—C21—C22 123.9 (3) H10A—C10—H10C 109.5 
C18—C12—C11 120.4 (3) H10B—C10—H10C 109.5 
C13—C12—C11 121.8 (3) O3—C16—H16A 109.5 
C13—C12—C18 117.6 (3) O3—C16—H16B 109.5 
O4—C11—C19 106.4 (3) O3—C16—H16C 109.5 
O4—C11—C12 106.5 (3) H16A—C16—H16B 109.5 
O4—C11—C7 107.8 (3) H16A—C16—H16C 109.5 
C12—C11—C19 112.7 (3) H16B—C16—H16C 109.5 
C12—C11—C7 119.1 (3) C29—C30—H30 119.7 
C7—C11—C19 103.5 (3) C29—C30—C31 120.5 (5) 
O6—C26—C20 115.9 (3) C31—C30—H30 119.7 
O6—C26—C25 124.2 (3) C3—C2—H2 119.9 
C20—C26—C25 119.8 (3) C1—C2—C3 120.2 (4) 
C21—C22—H22 122.1 C1—C2—H2 119.9 
C23—C22—C21 115.8 (3) C4—C5—H5 119.7 
C23—C22—H22 122.1 C6—C5—C4 120.6 (4) 
C17—C15—O3 115.9 (3) C6—C5—H5 119.7 
C14—C15—O3 123.8 (4) C2—C1—H1A 120.6 
C14—C15—C17 120.2 (4) C6—C1—C2 118.9 (4) 
O7—C35—N2 111.3 (3) C6—C1—H1A 120.6 
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O7—C35—C19 112.8 (3) C29—C34—H34 120.3 
O7—C35—C8 108.2 (3) C29—C34—C33 119.3 (5) 
N2—C35—C19 106.2 (3) C33—C34—H34 120.3 
N2—C35—C8 112.4 (3) O6—C27—H27A 109.5 
C8—C35—C19 105.8 (3) O6—C27—H27B 109.5 
C35—C8—H8 108.0 O6—C27—H27C 109.5 
C9—C8—C35 109.6 (3) H27A—C27—H27B 109.5 
C9—C8—H8 108.0 H27A—C27—H27C 109.5 
C9—C8—C7 118.4 (3) H27B—C27—H27C 109.5 
C7—C8—C35 104.5 (3) C5—C6—H6 119.5 
C7—C8—H8 108.0 C1—C6—C5 121.1 (5) 
O5—C23—C22 124.3 (3) C1—C6—H6 119.5 
O5—C23—C25 113.3 (3) C34—C33—H33 119.8 
C22—C23—C25 122.4 (3) C32—C33—C34 120.5 (5) 
C12—C18—H18 119.2 C32—C33—H33 119.8 
C17—C18—C12 121.5 (3) C30—C31—H31 119.8 
C17—C18—H18 119.2 C32—C31—C30 120.3 (6) 
C3—C4—C7 119.2 (4) C32—C31—H31 119.8 
C5—C4—C7 122.8 (3) C33—C32—H32 120.0 
C5—C4—C3 118.0 (4) C31—C32—C33 119.9 (5) 
C15—C17—H17 120.1 C31—C32—H32 120.0 
C18—C17—C15 119.7 (3) Cl1S—C1S—H1SA 108.3 
C18—C17—H17 120.1 Cl5S—C1S—H1S 109.9 
O2—C9—C8 114.4 (3) Cl3S—C1S—Cl1S 107.1 (3) 
O1—C9—O2 122.5 (4) Cl3S—C1S—H1SA 108.3 
O1—C9—C8 123.0 (4) Cl4S—C1S—Cl5S 105.8 (4) 
C26—C25—C23 119.1 (3) Cl4S—C1S—H1S 109.9 
C26—C25—H25 120.4 Cl2S—C1S—Cl1S 111.7 (3) 
C23—C25—H25 120.4 Cl2S—C1S—H1SA 108.3 
C11—C7—H7A 106.2 Cl2S—C1S—Cl3S 112.9 (3) 
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C8—C7—C11 105.2 (3) Cl6S—C1S—Cl5S 108.0 (4) 
C8—C7—H7A 106.2 Cl6S—C1S—H1S 109.9 
C4—C7—C11 115.6 (3) Cl6S—C1S—Cl4S 113.2 (4) 




5. Biological Evaluation of Amidino- and Amino-Rocaglates: 
5.1 FF/HCV/REN Assay: 
In vitro translation assays: Experiments evaluating translation inhibition were performed 
as previously described.S1 Briefly, Krebs-2 translation extracts were supplemented with 4 
mM MgCl2, 30 mM Tris-HCl (pH 7.5), 1.5 mM ATP, 0.1 mM GTP, 0.6 mM CTP, 10 mM 
dipotassium creatine phosphate, 80 g/mL creatine kinase, and 0.04 mM amino acids, and 
programmed with 10 ng/L reporter mRNA (psp6(CAG)33FF/HCV/Ren). Reactions were 
incubated with the indicate concentration of compound for 60 minutes at 30 oC prior to the 
measurement of firefly and renilla luciferase activity (Lumat LB 9507 Tube Luminometer 
- Berthold Technologies). 
5.2 SAB Cell Viability Assay: 
Sulforhodamine Assay (SRB): MDA-MB-231 breast cancer cells were seeded at a density 
of 1000 cells per well in a 96 well plate and, on the following day, compounds were added 
to the indicated concentrations and the cells were cultured in the presence of compound for 
4 days. To assess relative viability, cells were washed with PBS buffer and were fixed with 
50% cold trichloroacetic (TCA) acid for 1 h. After fixing, the TCA was removed by 
washing the wells 5 times with water and cells were stained with a solution containing 0.5% 
SRB in 1% acetic acid for 10 minutes at room temperature. The wells were then washed 5 
times with 1% acetic acid to remove the unbound SRB and plates were air dried. The bound 
dye was resolubilized in 10 mM Tris (pH 9.0) and quantitated using a Spectramax M5 at 








   
FF/HCV/REN 
   
SRB Cell 
Viability 
   
 
   
FF/HCV/REN 
   
SRB Cell 
Viability 






   
FF/HCV/REN 
   
SRB Cell 
Viability 
   
 
   
FF/HCV/REN 
   
SRB Cell 
Viability 






   
FF/HCV/REN 
   
SRB Cell 
Viability 
   
 
   
FF/HCV/REN 
   
SRB Cell 
Viability 






   
FF/HCV/REN 
   
SRB Cell 
Viability 
   
 
   
FF/HCV/REN 
   
SRB Cell 
Viability 






   
FF/HCV/REN 









   
SRB Cell 
Viability 






   
FF/HCV/REN 
   
SRB Cell 
Viability 
   
 
   
FF/HCV/REN 
   
SRB Cell 
Viability 
   
S59 
 
5.4  F163L Point Mutant within eIF4A1 Rescues ADRs’ Cytotoxicity. 
 
Method Description: The eIF4A1em1jp cell line was generated according to our reported 
protocol.S6 SRB assays were performed using the same protocol describe above (cf. page 
S52). The cytotoxicity of (+)-9aa and (-)-9aa in the eIF4A1em1jp cells was likely caused by 
inhibition of the remaining wild-type eIF4A2 paralog in the cells. We rationalize that the 
minimal cytotoxicity induced by unnatural enantiomer (+)-9aa was approximately 100-
fold less than that of (-)-9aa and that cytotoxicity may be due to a trace amount of (-)-9aa 
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